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Aims/hypothesis: The purpose of the study was to estimate the prevalence and risk factors for 
diabetic peripheral neuropathy (DPN), and additionally, evaluate the sensory and 
musculoskeletal lower-leg function, in type 2 diabetic outpatients, attending the BIRDEM 
hospital in Bangladesh. 
 
Materials and methods: Type 2 diabetic outpatients, diagnosed 5-11 years prior the 
investigation was randomly drawn. The Neuropathy Symptom Score (NSS) and the 
Neuropathy Disability Score (NDS) was employed to assess DPN. Data about socio-
demographic characters, blood pressure, height, weight, waist and hip circumference, and 
random blood and urine samples were collected. For the lower-leg function evaluation, the 
plantar cutaneous sensation (Semmer-Weinstein 5.07 g monofilament), 1st MTP and ankle 
joint rang of motion (ROM) (goniometry) and muscle function (Kendall’s muscle test) in 
addition to balance (one and two leg static balance, tandem walk) was examined. 
 
Results: Two hundred and ninety four (139 men, 155 women) type 2 diabetic outpatients were 
studied. The overall DPN prevalence was 19.7 %, male (20.9%) and female (18.7 %). The 
prevalence rate increased with increasing age (from 11.1% in the 23-40 year-old group to 
32.3% in the 60-80 year-old group) and duration of diabetes (from 14.1% in patients with 5 
years to 29.2% in patients with 9-11 years duration). Age > 60 years (OR 4.2, 95% CI 1.4 – 
12.3), low/normal WHR (OR 3.8, 95%CI 1.6-9.3), treatment with insulin (OR 2.0, 95% CI 
1.0-4.0) and income < 800 TK (OR 3.1, 95% CI 1.1-9.3) were independent, statistically 
significant risk factors for the occurrence of DPN, longer duration of diabetes (OR 1.2, 95% 
CI 1.0-1.4) and higher HbA1c (OR 1.1, 95% CI 1.0-1.3) were independent, borderline 
statistically significant risk factors for DPN. The 1st MTP dorsal (p=0.03) and plantar flexion 
(p=0.003) joint ROM, the Tibialis anterior (p=0.03) and Flexor hallucis (p=0.02) strength, 
balance (<0.001) and protective sensation (p<0.001) was statistically significant diminished in 
the DPN group compared to the non-DPN-group. After controlling for age, protective 
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sensation, balance, 1st MTP plantar and dorsal flexion ROM, and Tibialis anterior and Flexor 
hallucis strength in a multivariate logistic regression model, the DPN-group still had reduced 
balance (OR 1.4, 95% CI 1.1-1.6), diminished protective sensation (OR2.0, 95% CI 1.5-2.6) 
and Flexor hallucis weakness (OR 3.2, 95% CI 1.1-9.4).  
 
Conclusions/interpretations: We observed a DPN prevalence of 19.7%. Higher age, low 
socioeconomic status and treatment with insulin were statistically significant risk factors, 
while longer duration of diabetes and poor glycemic control were borderline statistically 
significant risk factors for DPN. The DPN subjects preformed worse on all the lower-leg 
function tests, especially for the protective sensation and balance test. They may therefore be 
at high risk for developing foot complications. In societies like Bangladesh, where the 
resources are scare, the awareness among patients and professionals should be raised. 
Necessary measures ought to be taken to prevent diabetes complication and secure the quality 
of care to reduce the burden and costs for both the individual family and the society at large.   
 
Key words:  Type 2 diabetes, peripheral neuropathy, risk factors, balance, strength, physical 
therapy techniques, plantar cutaneous sensation 
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1. INTRODUCTION  
1.1. A brief country profile 
1.1.1. Geography  
Bangladesh is located on the largest delta in the world and boarders to the Bay of Bengal, 
Burma and India. The country is flat and low, and only a small area lies more than 12 meters 
above sea level. Consequently, one third of the country floods during the annual monsoon 
rainy season. The total area is 144,000 km², with 133,910 km² being land. The climate is for 
the most of the year tropical and humid with high temperatures.(1) 
1.1.2. History  
Bangladesh became a part of British India during the 16th century when the British dominated 
the South-Asian region. India became independent in 1947, and simultaneously West Pakistan 
and East Bengal, both primary Muslims, separated from India, primary Hindu, and became 
the new country of Pakistan. East Pakistan (East Bengal) separated from West Pakistan in 
1971, and was renamed Bangladesh. Today the official name is People's Republic of 
Bangladesh, and the capital is Dhaka.(1)   
1.1.3. Economy 
Bangladesh has done eminent financial and social progress since the independents in 1971. 
The GDP has been rising the last twenty years. In 2006 the GDP real growth rate was 6.1% 
(2200 US$ (purchasing power parity) per capita)(1). More than half of GDP is generated 
through the service sector. The country is now more or less self-sufficient with food. Rice is 
the single most important product, followed by jute, tea, wheat, sugarcane, potatoes, tobacco, 
pulses, oilseeds, spices and fruit. Unfortunately, still 45% of the population lives below the 
poverty line and the disparity between rich and poor are increasing(2). The explanation for the 
slow growth in Bangladesh is said to be due to the frequent cyclones and floods, a rapidly 
growing labour force that cannot be absorbed by agriculture, slow implementation of 
economic reforms and inefficient state-owned enterprises, corruption, inadequate port 
facilities, delays in exploiting energy resources (natural gas), in addition to insufficient power 
supplies. The poverty, inequality and overpopulation is therefore maintained(1).  
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1.1.4. Politics 
Bangladesh is governed by a parliamentary democracy with a president chosen by the 
parliament. There are two major political parties, the Bangladesh Nationalist Party (BNP) and 
the Awami League (AL). The BNP came to power during the last election in 2001. In 
accordance with the constitution, a neutral caretaker government undertook the power in 
October 2006, with the intention to hold an election in January 2007. The political situation 
has for that reason been very tense with strikes (hartal) and demonstrations since August 
2006. The opposition party demanded several measures in order to secure a rightful election. 
These measures where not made. It resulted in a state of emergency and no election was held. 
The neutral government gave away the power to a military acting government, who have 
promised to hold an election in the near future, but not published any date(2).  
1.1.5. Population 
The total population counted 147.4 millions in 2006, with a population growth rate of 2.09% 
(1). The urban population grows more rapidly. Today there are approximately 17 million 
inhabitants in Dhaka, and the number is expected to pass 20 million within 2020(3). 
Overpopulation and urbanization has resulted in slum formations, and the United Nations 
human settlements program has stated that immediate, urgent action that need to be taken to 
slow down or reverse slum trends.   
 
Bangladesh is known to be a moderate Muslim country with 83 % of the population being 
Muslims and 16 % being Hindus(1). However, several observers have noticed that Muslim 
fundamentalism is growing(2). The official language is Bangla, which is spoken by 98% of 
the population. Even though the education system is improving, only 43.1% of the total 
population aged 15 and over can read and write(1). Two-thirds of Bangladeshis are employed 
in the agriculture sector, and a great majority works in the informal sector, are unemployed or 
underemployed(1). 
1.1.6. Lifestyle  
The food in Bangladesh is spicy and often fried in oil. Rice is the main staple food, and eaten 
to almost every meal. It is relative cheap compared to vegetables, and very cheap compared to 
quality meat, chicken and fish. Regional data show that the mean consumption of fruit and 
vegetables is very low. The daily intake of fibre and protein compared to highly processed 
carbohydrates is therefore relative small. The food composition and intake is related to the 
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socioeconomic status(4), which also counts for the type of occupation and activity level. 
Traditionally, populations of South-Asian countries have been mainly agrarian workers, 
whose levels of occupational physical activity have been high. Rapid socio-economic 
transition and urbanization has resulted in more people undertaking industrialized jobs, and a 
general decline in the physical activity level(5). 
 
Bangladesh is in a stage of demographic transition where the proportion of the elderly 
population is increasing. In addition, the country is facing an epidemiologic transition, which 
means that there is a shift from predominantly nutritional deficiencies and infectious diseases, 
to those classified as degenerative diseases, as the major causes of death(4). The country is 
therefore facing a double burden of disease. The infant mortality rate is 60.83 deaths per 1000 
live births, and the life expectancy age at birth for the total population is 62.46 years(1). 
1.1.7. Health care system 
The control of the Government of Bangladesh (GOB) health services is highly centralized 
within the Ministry of health and family welfare (MOHFW), which has the overall 
responsibility for health sector policy and planning. There MOHFW has been divided into a 
health services directorate and a family planning directorate, but are now organized into more 
joint services at the district level. Even though the MOHFW carry the responsibility for the 
health care services, the non-governmental (NGO) and voluntary social organisations (VGO), 
which include both for-profit and non-profit organisations, predominates the provisions(6). 
Therefore the individual’s first consultation is largely depending on the symptoms, gender, 
socioeconomic status and geographic location. The GOB tends to contact the NGO’s and 
VGO’s to work in specific areas or to carry out special programs. 
  
The diabetes care is mainly delivered by the Diabetic Association of Bangladesh (DAB), a 
non-profit medical VGO registered with the Ministry of Social Welfare. It was established in 
1956 and started the first out-patient clinic in Dhaka in 1957. Today there are 64 DAB 
affiliated associative throughout the country. Over the years the clinic in Dhaka has turned 
into a diabetes care and research complex named the Bangladesh Institute of Research and 
Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)(7).  
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1.2. Diabetes mellitus  
Diabetes mellitus (DM) is a metabolic chronic disease that occurs when the beta cell in the 
pancreas does not produce enough insulin, or when the body cannot effectively use the insulin 
it produces(8). The aetiology is multi-factorial. DM may be presented with symptoms like 
thirst, blurring of vision and weight loss, or with non-specific symptoms like depression and 
decreased working capacity(9). Hyperglycaemia is a common consequence of uncontrolled 
diabetes. Over time it will may lead to serious and costly complications to many of the body's 
systems, especially the nerves and blood vessels(8).  
 
The WHO has estimated that 180 million people have DM today. The total number of people 
with diabetes and its complications are rising worldwide, and is predicted to rise to 366 
million by the year 2030(10). The DM epidemic can partly be explained by increased average 
life expectancy, obesity, sedentary lifestyle and a changed dietary pattern(9). The highest 
increase is projected to be found in the urban population in developing countries, especially in 
South-Asia. Further, this part of the world features a situation where the diabetes population is 
relative young (45-65 years) compared to the West (above 65 years)(11;12). 
 
The prevalence of DM in Bangladesh is found to be 8.1% in the urban and 2.3% in the rural 
population(11). Both figures are high compared to the West (1-2%)(13). In the view of the 
high prevalence rate and low age among diabetic patients it can be assumed that Bangladesh 
is facing a high number of diabetes complications(12).  
1.2.1. Diabetic neuropathy   
Diabetic neuropathy is damage to the nerves as a result of DM, and the most common 
complication of DM. Chronic distal sensorimotor symmetrical neuropathy (diabetes 
peripheral neuropathy (DPN)) is the most common form and accounts for 75% of the diabetic 
neuropathy syndromes(14). It is defined as the presence of symptoms and/or signs of 
peripheral nerve dysfunction in people with diabetes, after exclusion of other causes(15). 
 
The International diabetes federation has estimated that DPN affects 20-50% of people with 
DM(16). The prevalence rates in the literature varies from 5-100%(17). This diversity may 
reflect the different diagnostic criteria and diverse study population. In Europe the prevalence 
is found to be between 20-60 % in patients who have had the DM diagnosis between 4 and 10 
years(18-20), but there are few DPN studies from the South-Asian region. A study from India 
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reported a DPN prevalence of 19.1%(21), and studies from the U.K. have reported lower level 
of peripheral arterial disease (PAD) and DPN among South-Asians compared to Europeans 
living in the U.K. (22;23). Age, duration of diabetes and the poor glycaemic control are 
recognized as risk factors for DPN, while cigarette smoking, retinopathy, hypertension, 
obesity, hyperlipidaemia and microalbuminuria has been pointed out as potential risk 
indicators(14). 
 
The primary symptom of DPN is loss of sensation in the toes which extends to involve the 
feet and leg in a stocking distribution. Some patients complain about numbness and pain, but 
most frequently the disease progresses insidiously and undetected. Loss of vibratory, tactile, 
pain and thermal perception, in addition to abnormal distal lower reflexes and pain or tingling 
feelings are early signs of DPN. It can be detected by means of the 10 gram Semmes-
Weinstein monofilament, 128 Hz tuning fork and a reflexes hammer. There is no uniform 
screening tool or guideline regarding the early evaluation and diagnosis of DPN, but several 
countries and federation have formulated suggestions. Neuropathy Disability Score (NDS) 
which includes the examination of the ankle reflex, vibration perception, pin prick sensation, 
and temperature in combination with the Neuropathy Symptom Score (NSS), which includes 
questions concerning burning, numbness or tingling feelings in the lower extremities, is 
recognized as a screening tool(14). 
 
If no appropriate preventive measures are taken and the disease progresses, motor 
manifestations like wasting of the small muscles in the feet and weakness of the lower 
extremities become apparent. Deformities and foot callus that can fissure, infect, and ulcerate 
might develop and further turn into painful and distressing impairments. Of all diabetes 
related lower extremity amputations, 85% are preceded by foot ulcers, and 70 % of all leg 
amputations worldwide happen to individuals with DM(15;24). In diabetic patients with 
severe foot ulcers the mortality figures are as high as 54%(12).  Most of the diabetic foot 
ulcers are considered to be of neuropathic aetiology(14), and therefore eminent preventable. 
The secondary diabetic neuropathy complications can therefore most likely be avoided, if  
neuropathy is identified at an early stage(15). 
 
Most of the studies in the field of motor dysfunction and joint mobility are qualitative studies 
from the West, where expensive testing instruments like e.g. Magnetic Resonance Image and 
motor nerve conduction velocity apparatus have been used. The results show that diabetic 
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patients have limited joint mobility, atrophy, additional to gait and balance problems(25-28). 
Clinical screening tests for mobility and strength are usually preformed by means of a 
Goniometry and Kendall’s muscle test.  
 
1.3. Justification of the study  
The prevalence of type 2 diabetes and its complications are predicted to increase extensively 
in the South-Asian region(10), especially among the urbane population. There are few 
diabetic neuropathy studies from the South-Asian region and to our knowledge, no published 
data on the DPN prevalence, or risk factors among type 2 diabetic patients in Bangladesh. 
Here expensive and modern equipment are less likely to be available, and costly treatment is 
out of reach for the majority of the people. Therefore the attention should be on easily 
arranged clinical tests, in addition to preventive measures to avert falls, fractures, work 
disability and hospitalisation among diabetic patients(12).  
  
Few studies have used objective clinical performance measures to study the relationship 
between diabetes, DPN and physical function. Considering the motor, sensory and functional 
impairment caused by DPN, an evaluation of the prevalence and unknown risk factors, in 
addition to an assessment the patient’s physical function become important in order to avert 
further disability and reduce the enormous medical, economic and social burden for both the 
individual and the societies.  
 
2. RESEARCH OBJECTIVES  
2.1. Objectives 
2.1.1. General objective: 
To estimate the prevalence of and associated risk factors for diabetic peripheral neuropathy, 
and additionally, evaluate the sensory and musculoskeletal lower-leg function among type 2 
diabetic outpatients in Dhaka, Bangladesh. With a view to provide necessary data to identify 
differential risk factors, and to identify diabetic patients at risk for developing foot 
complications in a practical and suitable manner, which may ensure improved preventive 
measures and the quality care for diabetic patients.  
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2.1.2. Specific objectives: 
1. To determine the diabetic peripheral neuropathy prevalence  
2. To identify the associations risk factors for diabetic peripheral neuropathy by 
• Mapping demographics and socioeconomic factors 
• Describing the food habits and physical activity level 
• Analyzing biophysical and biological data in relation to DPN  
3. To assess and describe the cutaneous sensation and musculoskeletal lower-leg 
function  
 
3. METHODS  
3.1. Location and Population 
The research took place in the out-patient department at BIRDEM hospital in Dhaka, 
Bangladesh, in the period 8th of August to 18th of September 2006. BIRDEM is a 550-bed 
general tertiary level hospital with most modern disciplines. The out-patient department 
(OPD) is largely dedicated to diabetic patients, with a daily turnover of around 3000 patients, 
including 60 to 70 new patients(7).  
 
3.2. Study design  
Due to limited resources and time a cross-sectional design was selected to obtain information 
regarding the DPN prevalence and associated risk factors, in addition to the assessment of the 
patients’ lower-leg function. 
 
3.3. Sample selection 
3.3.1. Inclusion criteria 
The inclusion criterion was routine visiting type 2 diabetic outpatients, diagnosed according 
to the WHO criteria 5-11 years prior to the investigation. The patients were registered at the 
BIRDEM hospital between the 1st of January 1996 and the 31st of December 2001, and had a 
registration number in the range 148971 – 238083. The patients with amputations were also 
included in order to estimate the correct prevalence rate.  
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3.3.2. Exclusion criteria 
The exclusion criteria were any known rheumatic disease, vitamin B12 deficiency, 
alcoholism, intoxication, hypothyroidism, hyperthyroidism, paraneoplastic disorders, cerebral 
vascular disease, Parkinson disease, uraemia and acute or chronic musculoskeletal disorders. 
3.3.3. Sample size calculation 
The determination of an appropriate sample size is most common in clinical trials, but it is 
also applied in cross sectional studies. The main idea behind a sample size calculation is to 
have a high chance of detecting a worthwhile difference between groups, if it exists. We 
wanted to identify associated risk factors for DPN. Therefore we would be interested to detect 
this difference for a number of variables with 80 % probability and a statistically significant 
level of 0.05, between the DPN subjects and the non-DPN subjects. We used the assumed 
proportion for one variable in the DPN group, p1, and the assumed proportion for the same 
variable in the non-DPN group, p2, to calculate the mutual p= (p1+p2)/2. The standardized 
difference was calculated with the formula: (p1-p2)/√(p(1-p)). The nomogram was used to 
calculate the sample size for detecting a difference for the defined variable (29).  
 
Figure 1:  Sample size calculation 
Sample 

















250 0.30 0.15 0.225 0.35921 0.8 0.05 
600 0.30 0.20 0.25 0.23094 0.8 0.05 
2000 0.30 0.25 0.275 0.11197 0.8 0.05 
 
Taking the WHR variable, we assume that 30% of the DPN-group had a normal WHR, 
compared to 20% in the non-DPN-group. The proportions to be compared for the WHR 
variable are thus 0.30 and 0.20, and we would for need 600 patients. In addition to this sample 
size calculation, we had to match the sample size to the limited time and budget. Therefore we 
decided to include 400 patients. 
3.3.4. Sample collection  
Three days before the outpatient’s doctor appointment, he/she delivers a blood sample and 
register with their personal registration number on a patient list in the OPD.  The patient list is 
distributed between ten examination-rooms. There are 2-6 doctors in each examination-room.  
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Depending on the number of patients allocated for each examination-room, 1-3 examination-
room(s) was randomly selected every day, following a simple random procedure. The patient 
list belonging to the selected examination-room(s) was collected by the researcher, and the 
personal registration numbers matching the registration range was singled out and clearly 
marked with a red pen. The doctors were well informed of the research objectives and the 
inclusion and exclusion criteria. The doctor informed and asked the selected patients (marked 
with red on the patients list), to make contact with the research department immediately after 
the doctor appointment. Due to the climatic conditions (heavy rainfall) and the ongoing 
political unrest, not all the registered patients came to the doctor appointment or to the 
research department.  The number of patient did therefore differ from day to day.   
  
3.4. Data gathering  
3.4.1. Preparation 
All the theoretical preparation and equipment purchase was done in Norway before the data 
collection. An academic in the field of community medicine translated the questionnaire, 
made for this research, and the Neuropathy Symptom Score (NSS) into Bengali.  
Training of the assistants 
Two research assistants (RA) were recruited for the study. They both had finished their 
master of science in nutrition. They were introduced to the questionnaire. The Bengali 
questionnaire and NSS were used as a guide to secure any language misunderstandings. The 
clinical tests were also introduced, explained and carried out on both of the RAs to make sure 
that they understood what to put in plain words for the patients.  
Pilot testing and Pre-study  
The Bengali version of the NSS and the questionnaire were pilot tested on five patients 
fulfilling the inclusion criterion. There were no remarks or misunderstandings, and therefore 
no changes were made after pilot-testing. The first examination day was considered as pre-
testing session, and seven patients were included. During the session some of the function 
tests, which included walking and great motions, were conducted and found to be strenuous, 
time-consuming and not manageable in the small space available. The range of motion 
(ROM) measurements was initially set to be categorized into limited or normal ROM. We 
found that all the pre-tested patients ended up in the normal group, which gave little 
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information regarding the variation. Therefore, the exact ROM measurements were written 
down and the number of function tests was reduced after the pre-testing session.  
3.4.2. Procedure   
The patients were referred by the doctors, informed about the project and gave informed 
consensus to the RA. The patients’ medical record book was handed in to the RA. The RA 
recorded the needed information, gave the patient an ID number, measured the waist and hip 
circumference, and interviewed the patients. The patients were examined by the researcher 
and delivered blood and urine to the laboratory technicians. The laboratory staff analysed the 
blood and urine samples at the BIRDEM hospital. The researcher gathered the blood and 
urine sample results.   
Medical record and Anthropometrics 
The medical record book consists of information regarding the patient’s DM condition, 
starting from the registration date up to the present date. Fasting glucose, OGTT levels, lipids, 
and height in addition to the present day’s weight and blood pressure measures were recorded 
from the patient’s medical record book. 
 
In case of any confusion, blood pressure and anthropometrical data was reassessed by the RA. 
Height was measured to the nearest centimetre and weight in kilograms. Blood pressure was 
noted by a standard mercury sphygmomanometer while seated with the arm supported on a 
table.  
 
The waist and hip circumference were measured in nearest centimetre, with a non-stretchable 
measuring tape. Waist circumference was defined as the midpoint between the iliac crest and 
lower margin of the ribs. Hip circumference was measured at the symphysis pubis. Both 
measurements were done with the patient standing and breathing normal. The wais-hip ratio 
was calculated. 
Questionnaire 
The questionnaire was made for this study. It was based on the questionnaires used in the 
revived articles, in addition to the “getting around” part in the World Health Organization 
Disability Assessment Schedule II. The questionnaire was structured, with clear closed ended 
questions divided into six sections: 
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1. Demographic characteristics: age, gender, years of education, occupation (student, 
housewife, manual work, office work, business, unemployed, retired), average 
monthly family income and living arrangements (electricity, pipe-water). 
2. Patient history: Diabetes duration and medication (diet, tablets, insulin), family 
diabetes, renal-, vision- and foot complications.  
3. Lifestyle.  
a. Smoking: never smoked, ex-smoker, occasionally smoker, <10 per day, 10-20 
per day or >20 per day.  
b. Food consumption: Vegetable, rice (<3 units, 3-7 units, >7 units per day),  
chicken, fish and beef (None or once, <3 times, >3 times per week)  
c. Physical activity level (Never, <30 minutes, 30-60 minutes, 1-2 hours, 2-4 
hours, > 4 hours per day,)  
d. Walking and standing difficulties (No, moderate, cannot do)   
4. Foot-care awareness: Type of foot-wear, feet cleaning (every week, every day, several 
times a day) and inspection practices (every day, every week, every month) 
Neuropathy Symptom Score 
Neuropathy Symptom Score(18) consist of five questions. The RA questioned the patients. If 
there were any vagueness or remarks the researcher was consulted. Each question was 
assessed with points in order to calculate the total symptom score. The total symptom score 
was calculated and converted into grade of symptom. 3-4 points were converted into mild 
symptoms, 5-6 points into moderate symptoms and 7-9 points into severe symptoms.  
1. Burning, numbness and tingling (2p) or Fatigue, cramping and aching (1 p) feelings in 
the lower extremity 
2. The feelings (symptoms) are present in the feet (2p) or calf (1p)  
3. There are nocturnal exacerbation of the feelings (symptoms) (2p) or they are equally 
present during the day and night (1p) 
4. The feelings (symptoms) wake the patient up from sleep (1p) 
5. Walking (2p) or standing (1p) manoeuvres reduce symptoms 
Neuropathy Disability Score  
The Neuropathy Disability Score (18) consist of four clinical tests. The RA explained the 
testing procedure and applied the tests at the patients hand prior to the initiation of the 
examination. The patient was examined in a supine position with the eyes closed for test 
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number 1-3. The researcher sat on the edge of the bench facing the patient feet to secure any 
cheating. Both feet were examined. Each test was assessed with points in order to calculate 
the total disability score. The total score was converted into grade of disability. 3-4 points 
were converted into mild disability, 5-6 points into moderate disability and 7-10 into severe 
disability.  
1. Pin-prick – tactile sensation was examined by using the reverse end of the turning fork 
and tendon hammer, which was sharp and dull respectively. Sharp followed by dull 
pressure, or in the opposite sequence, was applied at the cuticle of the 1st toe. The 
patient was asked to tell which application that was sharp or dull, correct answer (0p), 
incorrect answer (1p). 
2. 128 Hz turning fork (Hartmann C128) – vibration was examined by placing the 
vibrating fork longitudinal on the 1st toe three times. The fork was struck on the 
examiners knee to create the vibration. In at least one out of three strikes the fork was 
stopped and not-vibrating prior to the application. The patient was asked to say yes 
when vibrating, and no when not. Two of three right answers were assessed as correct 
(0p), whereas one of three right answers was assessed as incorrect (1p).  
3. Cold sponge: thermal sensation was examined by using a cold (from the freezer) and a 
room temperature sponge. Cold followed by normal, or in the opposite sequence, was 
applied on the dorsum of the foot. The patient was asked to tell which application that 
was cold and normal, correct answer (0p), incorrect answer (1p).  
4. Tendon hammer (Babinski hammer) – Achilles tendon reflex was assessed with the 
patient in sitting position. The broad end of the hammer was hit at the Achilles tendon. 
A jerk into dorsal flexion was attained (0p), with reinforcement (1p), and if no jerk 
(2p).  
Lower-leg examination   
The screening instruments were clinical. The RA explained the testing procedure prior to the 
examination. The researcher examined all the patients. 
1. Cutanus pressure perception was examined following the practical guidelines on the 
prevention of diabetic foot, by means of a 10g  (5.07 Semmer-Weinstein) 
monofilament (30). The patient was examined in a supine position with eyes closed. 
The examiner sat on a chair facing the patient’s foot soles. The monofilament was 
applied perpendicular to the skin surface with sufficient force to cause the filament to 
bend before it was removed. Both feet were examined on three plantar test sites: the 
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heel, 1st and 5th metatarsal head(20). The patient was asked to tell if he felt the 
pressure applied and required to respond (yes/no). The application was repeated three 
times at the same site with at least one “false” application, in which no filament was 
applied. Protective sensation was considered to present at each site if the patient had 2 
of 3 correct answers (0p), and lost in the patient had 2 out of 3 incorrect answers (1p). 
The maximum total sum score for both feet was 6 points. 
2. Range of motion measure with a goniometry (31). The exact angel measurement was 
written down. For the ankle joint the normal ROM is 10-20 degrees for dorsal flexion 
and 20-45 for plantar flexion. For the 1st MTP the normal ROM is 20-45 degrees for 
both dorsal and plantar flexion. 
a. Ankle dorsal and plantar flexion was examined with the patient in prone 
position and 90 degrees knee flexion. The stationary arm of the goniometry 
was placed parallel to the lateral midline of the fibula, projecting towards the 
fibular head. The axis was 1cm distal to the lateral malleolus of fibula, and the 
moving arm placed parallel to the lateral midline of the calcareous.  
b. Plantar flexion of the 1st MTP joint was examined with the patient in prone 
position and 90 degrees knee flexion. The stationary arm of the goniometry 
was placed over the dorsal aspect of the shaft of the first metatarsal bone. The 
axis was over the dorsal aspect of the MTP joint Moving arm: placed along the 
dorsal surface of the shaft of the proximal phalanx.  
c. Extension (dorsal flexion) of the 1st MTP joint was examined with the patient 
standing and facing the wall. The 1st toe was placed at the wall with the foot in 
the floor. The stationary arm of the goniometry was placed over the plantar 
midline shaft of the first metatarsal bone. The axis was over the plantar aspect 
of the MTP joint, and the moving arm placed along the plantar shaft of the 
proximal phalanx.   
3. Strength graded according to the Kendall’s muscle test (32). The researcher supported 
the patient if there were any balance problems. The grading was 0 if no contraction is 
palpable, 1 if contraction is palpable with no joint motion, 2 if the subject moves 
through small motion with gravity minimized, 3 if the subject moves into and holds a 
test position against gravity, 4 if the subject moves into and holds test position against 
gravity, against less than maximal resistance (<10 steps) and 5 if the subject moves 
into and holds test position against gravity, against maximal resistance (>10 steps). 
 21
a. Ankle flexors (Gastrocnemius, Soleus, Plantaris) were evaluated in standing 
position. The patient was asked to go up on tiptoe 10 times. If the patient did 
not manage to go up on tiptoe he was asked to do the plantar flexion 
movement lying prone, then in supine. 
b. Ankle extensors (Tibiales anterior) were evaluated in standing position. The 
patient was asked to walk 10 steps on the heels. If the patient did not manage 
to go up on heel, he was asked to do the dorsiflexion movement lying supine.  
c. Flexor hallucis brevis and longus and Extensor hallucis brevis and longus were 
evaluated with the patient sitting on the edge of the table with the knees flexed. 
Resistance was applied beneath the proximal and distal phalanx of the great toe 
and to the dorsum of the proximal and distal phalanx of the great toe. The 
patient was asked to keep the normal position, and not let the examiner move 
the toe. It the patient could not withstand the resistance he/she was asked to do 
the flexion and extension movement of the 1st MTP and IP joints without any 
resistance.  
4. Balance was examined by use of a modified index for muscle function test for the 
lower extremity(33). Each test was evaluated on a three point scale, 0 being the best 
score. The maximum abnormal total sum score for both feet was 8 points. 
a. One leg standing with the eyes open for 30 seconds, both feet was examined. 0 
points: > 30 sec, 1 point: 15 – 29 sec, 2 points: 0 – 14 sec. 
b. Narrow two leg standing with the eyes closed for 30 seconds. 0 points: > 30 
sec, 1 point: 15 – 29 sec, 2 points: 0 – 14 sec. 
c. Tandem walk on a 2 meter red line with eyes open. 0 points: carry out the test 
without problems; 1 point: carry out the test with some difficulties; 2 points: 
not able to carry out the test.  
5. Peripheral vascular status(34)  
a. The dorsalis pedis and posterior tibial pulse was palpated with the 2nd and 3rd 
finger. Each pulse score 0 when present and 1 when absent, on either foot. 
Max total score for both feet was 2 points. 
b. Capillary refill time of great toe was measured by applying pressure to the 
plantar side of the 1st MTP. The capillary refill time was timed.  
6. Ulcer was assessed by using a Modified Meggit-Wagner Ulcer Classification. No 
ulcer gave 0 point, superficial ulcer gave 1 point and full-thickness ulcer gave 2 
points. The maximum total score for both feet were 4 points. 
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7. Deformity was assessed by using a scale made for this study.  The deformities 
measured were: Hammer or claw toes (The proximal toe joint is fixed in flexion 
whiles the distal joint and the MTP joint are extended), Hallux valgus (Prominence of 
the 1st metatarsal head, the first toe is inclined latteraly and often rotated so the nail 
faces medially), Charcot arthropathy/Neuropathic arthritis (Form of osteoarthritis, 
destruction of articular cartilage. The ligament and capsule are lax, and the 
movements’ increased. There is new bone formation that can be felt. Increased fluid.), 
Pes cavus (The arch is higher than normal, and the heel is in varus position. Often 
there is claw toes.), and Pes plantus/Flat foot (The arch has collapsed so that the 
medial boarder of the foot almost touches the ground). Each deformity scored 1 point 
when present and 0 point when absent. The maximum total score for both feet were 10 
points.  
Blood and Urine samples  
The patients were asked to deliver random blood and urine in the research department after 
the interview and clinical examination. A water proof resistant marker was used to label the 
Eppendorf tubes with the patients ID number, one prime and one original. 
1. Blood samples. One test tube and one Eppendorf tube (8 ml in total) non-fasting 
whole blood were drawn. The Eppendorf tube was stored in a refrigerator and send to 
the laboratory every morning for HbA1c assessment. The test tube with the blood was 
centrifuged immediately after the examination every afternoon. The serum was 
collected in two Eppendorf tubes, stored in a freeze and sent to the laboratory for lipid 
analysis at a convenient (available capacity) time.  
 
2. Urine samples. Every patient was given a sterile test tube and asked to deliver urine. 
The urine was put in two Eppendorf tubes, stored in the freeze and sent to the 
laboratory for analysis at a convenient (available capacity) time. 
 
3.5. Variable definition 
3.5.1. Diabetic Neuropathy 
A total symptom score of 3-4 points was considered as mild symptoms, 5-6 points as 
moderate symptoms and 7-9 points as severe symptoms. A total disability score of 3-5 points 
was considered mild disability, 6-8 points as moderate disability and 9-10 points as severe 
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disability. The minimum acceptable criteria for diagnosis of DPN were moderate disability, 
with or without symptoms, or mild disability with moderate symptoms. Mild disability alone 
or with mild symptoms was not considered adequate to make a diagnosis of DPN(18). 
3.5.2. Demographic and socioeconomic factors 
The exact age and diabetes duration was categorized into three groups being; < 40, 41-59 and 
> 60 years old and < 6, 7-8 and > 9 years of duration. The monthly household income was 
divided by number of household members. The monthly income per family member was 
categorized into three groups; < 800, 801-2 999 and > 3000TK. The patients were asked about 
their food consumption. Chicken, fish and beef were added, renamed protein intake and 
categorized into low (0-4 points), middle (5 points) and high (6-9 points) protein intake.  
3.5.3. Anthropometrics  
Body mass index (BMI) was calculated according to the formula BMI = weight/height2 
(kg/m²). According to the WHO recommended cut-off points underweight was defined as < 
18.4, normal weight as 18.5-24.9, overweight as 25-29.9 and obesity as > 30. The wais-hip 
ratio was calculated by dividing the waist and hip circumference measured in centimetre. A 
WHR > 0.90 in men and > 0.80 in women is seen as abdominal obesity and a risk factor for 
developing diabetes(35). Hypertension is defined as systolic blood pressure > l40 mmHg or 
diastolic pressure > 90 mmHg(36).  
3.5.4. Biological specimens  
Glycosylated hemoglobin (HbA1c) was analysed by high-performance liquid chromatography 
(HPLC). Good glucose control was defined as HbA1c < 7.0% (37). The total cholesterol (TC) 
was measured using conventional laboratory techniques. The urine creatinine level was 
measured by the Alkaline  Picrate (Hitachi 704 Japan) method in the biochemical laboratory, 
and urine albumin by the Nephelometry (Bn-2 Nephelometer) method in the 
laboratory(38;39). The detection limit for albumin was 11, 6 mg/l. The urinary albumin-to-
creatinine ratio (UACR) was calculated. A value < 2,5 mg/mmol was defined as normal, 2,5-
30 mg/mmol as microalbuminuria and >30 mg/mmol as for manifest proteinuria(40).  
3.5.5. Sensory and musculoskeletal lower-leg function  
Cutanus pressure perception was categorized into present (2 of 3 correct answers (0p)), or lost 
(1 of 3 correct answers (1p)) for each test site. The scores for each site for both feet were 
added and categorised into normal (0p), reduced (1p) and absent (2p) protective sensation.  In 
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addition the total protective sensation sum score was calculated, the maximum abnormal 
score was 6 points. The balance test included 4 tests, each graded on a three point scale and 
categorised into good (0p), problems (1p) and not able to perform the test (2p). In addition the 
total balance sum score was calculated, the maximum abnormal score was 8 points. The 
Kendall’s muscle test scales from 0 to 5 points. The points for each muscle group for both feet 
were added and categorised into strong (10-8 p) and weak (7-0 p). The joint ROM measures 
for each joint for both feet were added, and the mean value was calculated.  
 
3.6. Ethical issues 
Approval was sought and given by the Ethical Committee in Norway and from the BIRDEM 
hospital, Bangladesh. The study was carried out according to the Helsinki declaration. The 
patients were informed about the purpose and objective of the study, and that they had the 
right to withdraw or restrict their data from analysis at any stage of the study. They 
volunteered and gave informed consent prior to being included in the study.  
 
Ethical difficulties raised in this study included the data collection on the topic of 
socioeconomic status and behaviour. The findings have been treated with highest possible 
degree of confidentiality. The uncomfortable feelings were limited, and were done by 
informing the participant that any question could be refused. The random blood and urine was 
delivered at the hospital to reduce the discomfort related to fasting and bringing urine to the 
hospital. The clinical assessment was preformed gentle and with care in order to prevent and 
limit possible uncomfortable and exhausting feelings. All the tests were explained and 
showed beforehand in order to secure any unexpected event. The patients’ transportation 
expenditure was covered as a compensation for participating in the study.  
 
3.7. Data handling  
The data was entered in the SPSS 14.0 for Windows software, every evening. After arriving 
Norway the data was transformed into Microsoft Excel 2003. In Excel the raw data was 
checked. Z-score and XY-plot was prepared in order to acquire an overview of the data 
material. Subsequently the data was converted again to SPSS 14.0 for Windows software for 
data analysis.  
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Descriptive statistics were used in order to identify the DPN prevalence, determined in simple 
percentages. For comparison of baseline variables between the groups, chi-square (χ²) test 
were performed for categorical data, t-test for normally distributed continuous data and 
Mann-Whitney test for non-normally distributed continuous data. Spearman correlation was 
used to assess the relationship between variables of interest. Bivariate and multivariate 
logistic regression analyses were performed in order to identify factors associated with DPN 
and adjust for potential confounding factors. Odds ratios (OR) with 95 % Confidence 




4.1. Main Demographic and socio-economic characteristics 
In this cross sectional study a total of 303 patients were interviewed and examined. One 
patient withdrew in the middle of the examination, one patient was excluded due to duration 
of diabetes of four years, three patients were excluded due to a history of stroke and four 
patients were excluded due musculoskeletal disorders (low back (L5) and ankle operations). 
A total of 294 patients remained for analysis.  
 
There were 155 (52.7%) female and 139 (47.3%) male. The mean age was 50.8 + 10.6 years, 
females being younger (48.7 + 10.7) compared to men (53.1 + 9.9).  The mean diabetes 
duration was 7.0 + 1.8 years, similar in both men and female. There were 82 patients who had 
a household income per family member of < 800 TK, 148 patients between 801-2 999 TK and 
64 patients > 3 000 TK. The mean education level was 6.8 + 5.2 years. 
 
Of the total number of patients, 49.7% were housewives, 13.3% had office work, 8.2% 
manual work and 11.2% reported business as their occupation, 6.1% were unemployed and 
11.6% were retired. Concerning the housing condition, 1 patient had only pipe-water, 78 
patients had only electricity, 212 patients had both and 3 patients had either pipe-water or 
electricity. First degree family diabetes was reported in 48.6% of the cases. Regarding any 
known diabetes complications only 9 (3.1%) patients reported impaired renal function, 
whereas 230 (78.2 %) reported vision impairment. There was one toe amputated patient (2nd 
and 3rd toe), and 46 patients with a foot deformity. A previous foot ulcer was reported in 28 
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(9.5%) patients and there were 18 patients with either superficial or deep ulcers the present 
day. Only 11 patients had a mean refill time of more that 3 seconds. In the DPN group17.2 % 
was not able to walk for one kilometre and 13.8% was not able to stand for half an hour 
compared to 3.8% for both functions in the non-DPN group. Due to the limited number of 
patients we decided not to use the data presented in this last paragraph for any further 
analysis.  
  
4.2. Paper 1 
The paper attempts to describe the prevalence of DPN and its associated risk factors for 
developing DPN among type 2 diabetic outpatients. The overall prevalence of DPN in this 
study was 19.7 %, which was fairly similar for male (20.9%) and female (18.7 %) patients. 
There was an increase in the prevalence of DPN with increasing age from 11.1% in those 
aged 23-40 years to 32.3% in those aged 60-80 years (OR 3.8, 95% CI 1.4-10.4). The 
prevalence of DPN increased steadily with increasing duration of diabetes per year (OR 1.2, 
95% CI 1.0-1.4), from 14.1% in those diagnosed 5 years prior to investigation to 29.2% in 
those having 9-11 years duration of diabetes  
 
The prevalence rate differed following the treatment procedures for diabetes. The prevalence 
of DPN was 13.7% in the oral antidiabetic treated group, compared to 29.2 % in the insulin 
treated group (OR 2.6, 95% CI 1.4-4.7). There were no significant correlation between the 
treatment procedure and age, or between the treatment procedure and duration of diabetes. 
There was a significant correlation between the treatment procedure and income (rSp = 
0.00135841; p< 0.001). The prevalence increased with decreasing income from 9.4% in the 
group earning > 3000 TK per month to 25.3% in the group earning < 800 TK per month (OR 
3.3, 95% CI 1.3-8.8), and with decreasing protein intake from 13.8 % in the group having a 
high protein intake compared to 32.8% the group having a low protein intake (OR 3.1, 95% 
CI 1.4-6.9). There was a significant positive correlation between protein intake and HbA1c 
(rSp = 0.00052095; p< 0.01), and between the protein intake and income (rSp = 0.000001; p< 
0.001). 
   
After controlling for age, duration of diabetes, HbA1c, treatment procedure, WHR and 
income in a multivariate logistic regression model, we found age > 60 years (OR 4.2, 95% CI 
1.4-12.3), low/normal WHR  (OR 3.7, 95% CI 1.5-9.3), income < 800 TK (OR 3.2, 95% CI 
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1.1-9.4) and patients treated with insulin (OR 2.0, 95% CI 1.0-4.0)  as statistically significant 
risk factors, and longer duration of diabetes (OR 1.2 95% CI 1.0-1.4) and higher HbA1c level 
(OR 1.1, 95% CI 1.0-1.3) as borderline, significant risk factors for DPN.  
 
4.3. Paper 2 
The aim of this study was to assess the sensory and musculoskeletal lower-leg function 
among type 2 diabetic outpatients, with and without DPN, in Bangladesh, in a valid and 
practical manner suitable for low income countries, in order to identify diabetic patients at 
risk for developing foot complications. We found that the protective sensation was 
statistically significant reduced for the heel (p<0.1), 1st toe (p<0.001) and 5th toe (p<0.001) in 
the DPN group compared to the non-DPN group. The statistically significant protective 
sensation reduction remained after calculating the total sensibility sum score (p< 0.001).   
 
The non-DPN group preformed better on the entire balance test, and the difference between 
the groups was statistically significant even after calculating the total balance sum score (p< 
0.001). For the tandem walk 92.8% of the non-DPN-group performed the test without 
problems compared to only 67.2% of the DPN-group. The DPN-group performed worse on 
both the right and left one-leg standing test. The highest statistically significant difference 
between the groups was found on the right one-leg (p<0.001) compare to the left one-leg 
(p<0.01) standing test.  
 
The joint ROM for both the ankle and 1st MTP joint was reduced in the DPN-group compared 
to the non-DPN group, but only the dorsal flexion (p=0.03) and plantar flexion (p=0.003) 
ROM of the 1st MTP joint was statistically significant reduced. A higher percentage of the 
DPN-group was weak in all the muscle groups compared to the non-DPN group, but the 
difference was only statistically significant for the Tibialis anterior (p=0.03) and Flexor 
hallucis (p=0.02) muscles.  
 
The results from the multivariate logistic regression analysis revealed that the DPN-group had 
a higher risk for poor balance (OR 1.4 95% CI 1.1-1.6), reduced protective sensation (OR 2.0, 
96% CI 1.5-2.6) and Flexor hallucis weakness (OR 3.2, 95% CI 1.1-9.4) even after 
controlling for age, balance, sensibility, 1st MTP plantar and dorsal flexion ROM and the 




5.1. Findings  
The general objective of the study was to estimate the prevalence and associated risk factors 
for diabetic peripheral neuropathy, and additionally, to evaluate the sensory and 
musculoskeletal lower-leg function among type 2 diabetic outpatients in Dhaka, Bangladesh. 
We wanted to do this in a practical manner suitable for low income countries like Bangladesh 
in order to identify diabetic patients at risk for developing foot complications. Further, we 
wanted to provide necessary data to identify differential risk factors that may ensure improved 
preventive measures and care for the diabetic patients. 
 
We found that the overall prevalence of DPN in this population was 19.7 %. European studies 
using similar diagnostic criteria, have reported prevalence rates of 32.1% (18),  35.4% (19) 
and  60.0 % (37) among type 2 diabetic patients attending diabetic hospital clinics. The low 
DPN prevalence in our study could be due to the selection of the study population. We 
included patients who were diagnosed with DM 5-11 years prior to the investigation, and 
consequently our subjects had a mean duration of diabetes of 7.03 + 1.80 years. The mean age 
of our subjects was 50.8 + 10.55 years, and therefore younger compared to the European 
subjects. They had a mean duration of diabetes of 6 years and a mean age of 63 years(18), 9.7 
years and 61.3 years(19), and 8.5 years and 57.2 years(37) respectively. This may indicate 
that the diabetes complications in the Bangladeshi subjects have initiated earlier both for the 
age and duration of diabetes and may confirm that the diabetes population in this part of the 
world is relative young compared to the West(11;12).  
 
The low DPN prevalence rate in our study corresponds with studies from the UK, showing 
that the neuropathy prevalence was lower in South-Asians compared with Europeans living in 
the UK, even after adjusting for age(22;23). It is also similar to the prevalence rate found in a 
study from a diabetic centre in India, reporting a neuropathy prevalence of 19.1% among type 
2 diabetic outpatients(21). The mean duration of diabetes in the Indian subjects with DPN 
were 12 years, and the mean age was 62 years. However, the Indian study employed different 
diagnostic criteria and no firm comparison or conclusion can therefore be made.  
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Population, recruitment, diagnostic criteria and modes of investigation are factors that may 
influence the differential results reported in various studies. We have used similar diagnostic 
procedures as those used in Young’s  study from the UK involving 6487 type 2 diabetic 
patients(18). They are simple clinical criteria without referring to electrodiagnostic studies, 
since highly sophisticated and expensive procedure is less suitable to undertake in developing 
countries like Bangladesh.  
 
Age, duration of diabetes and poor glycemic control are established risk 
factors(14;18;19;21;36;37;41-43), which we revealed as risk factors for DPN. Duration of 
diabetes was found to be a marginally independent, statistically significant risk factor for 
DPN in our population. This may be due to the limited sample size, in addition to the 
uncertainty between disease onset and time of diagnosis, which may indicate late diagnosis of 
DM. 
 
The BIRDEM hospital has a welfare system for economically underprivileged patients that 
provides them with insulin for free, or for a subsidized price. This might have resulted in 
more insulin treatment among the poorer patients, and explain the statistically significant 
correlation we found between the treatment regime and income. Although dubious, but in 
agreement with several other studies(21;37;42), we found  more subjects with DPN to be 
insulin treated. This finding remained even after controlling for the confounding factors age, 
duration of diabetes, income, WHR and HbA1c in a multivariate logistic regression model.  
 
We also found low income as an independent, statistically significant risk factor for DPN, 
which is in agreement with the findings from India, demonstrating that poor socioeconomic 
background contributes to diabetic foot complications(12). A possible explanation could be 
that the poor people are less likely to use health services(44), which might result in late 
diagnosis and uncontrolled DM. The statistically significant correlations we identified 
between protein intake and income, and protein intake and HbA1c may also strengthen the 
impact of socioeconomic level as a factor. The reason is that proteins and fibre-rich food are 
expensive and important in order to control the blood sugar level(45). It is reported that 
members of the higher social classes in Bangladesh are the first once to change from a low-
risk to a high-risk way of life, characterized by diets rich in animal proteins and a sedentary 
lifestyle(4). The socioeconomic status might therefore in turn explain for why low/normal 
WHR is a risk factor for the development of DPN in our study.  
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We used several easily arranged and inexpensive clinical tests to assess the sensory and 
musculoskeletal lower-leg function. The 10 gram monofilament is frequently used to assess 
the foot ulcer risk status. It is simple to perform, but general agreement is lacking regarding 
the type of monofilament, number of test sites and procedure. We used the Semmer-
Weinstein 5.07 (10 g) monofilament at three plantar sites for detecting loss of cutaneous 
pressure perception. For the 5th toe, 3.4% of the non-DPN group compared to 20.7% of the 
DPN group had absent protective sensation, which places them at high risk for developing 
foot complications. The 5th MTP test site has been reported to have the highest sensitivity 
compared to the hallux, 1st MTP and 3rd MTP test sites(46). 
 
Besides increasing the foot ulcer risk, loss of plantar cutaneous pressure perception might 
increase the risk of falling and postural instability (47) due to the lack of accurate 
proprioceptive feedback (sensory ataxia)(48). In addition to the afferent information from the 
somatosensory system, balance is controlled on the basis of the visual and vestibular system. 
As diabetes retinopathy appears to exist frequently with DPN, this will naturally affect the 
balance performance. We were not able to assess the retinopathy and DPN patients separately. 
However, large studies have reported that postural control is affected in DPN patient even 
with normal vision(48-50). Our findings is in agreement with others showing that DPN 
patients perform worse on a one-leg static balance test, compared to controls(51-53). We 
found that the difference between the groups for the one-leg standing test was most significant 
for the right leg compared to the left leg standing test. We did not ask the patients to identify 
their dominant and non-dominant leg, and can therefore not draw any conclusions. However 
the finding is interesting seen together with Cimbiz et al. who reported the right leg to be the 
dominant in the majority of his subjects, and further that the maximal balance reduction in the 
DPN group was found on the dominant leg(53).  
 
Limited joint ROM can also contribute to reduced balance as well as elevate the foot pressure, 
and consequently predispose to foot ulceration(54). We did not assess the plantar foot 
pressure, but studies using plantar pressure analysers have reported that DPN patients have 
elevated foot pressure in addition to reduced ankle and 1st MTP joint ROM(54;55). Zimney et 
al. reported the determination of the 1st MTP ROM to be a fairly exact test to identify a foot 
with elevated plantar pressure(54). Like others we found a statistically significant difference 
in the 1st MTP joint ROM between the groups(54), but this difference was lost when we 
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controlled for age, strength, balance and protective sensation. We did not observe any 
statistically significant difference between the groups for the ankle plantar and dorsal flexion 
ROM measured with a goniometry, which is in agreement with others(56). 
  
The relation between motor dysfunction and the severity of neuropathy and muscle strength 
remain largely unknown(57). However, magnetic resonance imaging, electromyography and 
electrophysiological studies of motor nerve conduction have revealed abnormalities and signs 
of atrophy, denervation and compensatory reinnervation in DPN patients(27;28;58). Atrophy 
of the foot muscles has been said to be closely related to the severity of neuropathy(57), and is 
believed to be the main processes leading to an anatomical foot change and therefore directly 
related to the development of foot ulceration(28) and postural instability(27). We found a 
significant difference between the DPN-group and the non-DPN-group for the Flexor hallucis 
(innervated by the nervus tibiale), but not for the Extensor hallucis (innervated by the nervus 
peroneal) muscle. This finding is in agreement with van Schie et al., who reported that the 
Tibial innervated muscles were weaker compared to the Peroneal innervated muscles in DPN 
subjects(26). 
 
The ability to stand on heels and toes are easily performed test that do not require any 
technical equipment and are therefore suitable for population based surveys(59). They reflect 
strength at the ankle and knee. In DPN, motor weakness is believed to result in foot drop and 
therefore it has been suggested more severe impairment of the ankle extensors (Tibialis 
anterior) compared to the ankle flexors(Gastrocnemius)(57). However, the findings in the 
literature are conflicting. Andersen et al. found similar degrees of weakness and atrophy of 
the ankle extensors and flexors(60), and has suggested that the functional differences between 
the extensors and the flexors is not caused by selective weakness or atrophy of the ankle 
extensors, but it is combined with a higher capacity of the ankle flexors and a consequence of 
the biomechanical properties of the ankle joint(57).  
 
5.2. Methodology  
5.2.1. Statistical analysis 
This is a cross-sectional study, which means that we have measured the condition, DPN, and 
the exposure, the associated risk factors, at the same point in time. Therefore we cannot draw 
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any firm conclusions regarding the risk factors. It is important to be aware that multiple 
factors may have influenced the dependent factor DPN. One variable may have a significant 
relationship with the dependent variable, but this association may have been due to the 
influence of a third variable, called a confounder factor. To control for the confounding 
factors we have used multivariate logistic regression analyses with DPN as the dependent 
factor. However, we cannot exclude the possibility that there might be uncontrolled factors 
that were not included in the study and analysis.  
5.2.2. Sample size 
We had limited time and recourses to conduct the study, and decided the sample size goal to 
be 400 patients. We manage to include 294 patients, which we stratified into two or three 
groups for some of the variables after the data collection. Ideally the number of subjects in 
each stratified group should have matched the sample size calculation. In theory this is 
possible, but in real life it is complex. One of the reasons for requiring a large sample size is 
to secure against a type II error. A type II error means that we run the risk of reaching a 
conclusion that there are no differences between the groups, even though there is a difference. 
The small sample size is a possible cause for only being able to identify the established risk 
factors like HbA1c and duration of diabetes, as borderline statistically significant risk factors. 
With a bigger sample size, it may be assumed that these risk factors would have become 
highly statistically significant.  
5.2.3. Selection bias 
Our sample was drawn from one hospital, the BIRDEM hospital, and the patients were 
diagnosed with DM 5 -11 years prior to the investigation. BIRDEM is the main diabetic 
hospital where all the diabetic patients in Dhaka come for diagnosis and follow-up. Since the 
research team only consisted of one researcher and two assistants, we had a limited capacity 
and were not able to include all the outpatients every day. To limit the selection bias, which is 
a distortion resulting from the manner in which the patients are selected, we did a random 
selection of the examination rooms every day. As we wanted the patients to deliver blood, 
which most patients find difficult during Ramadan, we decided to finish the sample collection 
before the start of Ramadan. This was also to secure any bias. 
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5.2.4. Response rate 
We wanted all the patients matching the registration range and fulfilling the inclusion 
criterion in the selected examination room(s), to make contact with the research department 
after the doctor appointment. To secure that the doctors asked the patients matching the 
registration range and fulfilling the inclusion criterion, the researcher personally talked to the 
doctors and marked the patient list every morning. The number of patients who made contact 
with the research department varied from day to day. The reasons could have been many.  The 
political situation resulted in several days with transportation strikes and unrest, which made 
it difficult for many patients and staff to attend the hospital. In addition, the rainy season also 
resulted in attendance problems. However, this has most unlikely biased the type of patients 
attending since the climate was similar for the whole city and the unrest took place in 
different city area almost every time. All the selected patients that turned up in the research 
department and fulfilled the inclusion criterion were included in the research.  
 
Covering the patients’ transportation expenditure, as a compensation for participating in the 
study, is a standard procedure in the research department at BIRDEM. The welfare system at 
BIRDEM enables patients from different socioeconomic levels to come to the hospital. To 
assure patients from all the socioeconomic levels, and ensure that the money was not the 
reason for the patients’ participation in the research, the information regarding financial 
compensation was not communicated and given before the end of the examination. However, 
we have no control of what was communicated to the patients and between the patients 
outside the research examination room.   
 
5.2.5. Validity 
Validity refers to whether one is able to measure what he/she intends to measure. It can be 
divided into internal and external validity. Internal validity is an estimate of how much the 
measurement is based on clean experimental techniques, which means that it is related to the 
instruments used. The biological specimens where analysed in the laboratory at the BIRDEM 
hospital, which is known to be one of the best laboratories in Bangladesh. This increases the 
internal validity of the study. We chose to use the NSS and the NDS to identify the DPN 
cases. The reason for choosing this testing instrument was that it is easy to perform and 
required minimal time. In addition it has been used in several large European studies(18;61), 
and even among South-Asians living in the U.K.(20). For the sensory and musculoskeletal 
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lower-leg examination we choose the Semmer-Weinstein 5.07 (10 g) monofilament(61), the 
goniometry(62) and Kendall’s muscle test(32) which has been used several times in previous 
studies. The index for muscle function test for the lower extremity has not been validated 
among diabetic patients. However, the balance tests we used have been used in other DPN 
studies.  
 
The NSS and the questionnaire made for this study was translated to Bengali to prevent any 
language misinterpretations. To increase the internal validity we pilot tested both the NSS 
translation and the questionnaire. Nevertheless, we failed to obtain any useful information 
regarding the patients’ physical activity level and foot-care practises. Physical activity is 
closely related to the occupation in Bangladesh, which were registered. In the Western 
countries, business this is closely related to a sedentary office work, whereas in Bangladesh, 
business is related a variety of jobs and can be everything from an office work, to running a 
small street shop or riding a rickshaw. For that reason we could not make any assumptions 
regarding the physical activity level. We were not able to evaluate the patients’ physical 
fitness level, since the research had to be limited to clinical tests that could be performed in 
the small research examination room.  
 
We asked the patients if they washed their feet several times a day, once a day, or once a 
week, but did not specify and defined what we meant by washing. In a predominantly Muslim 
country like Bangladesh, a large proportion of the people wash their feet several times a day 
before praying. Almost all patients replied that they washed their feet several times a day. 
This may reflect a certain misunderstanding regarding the type of wash, and that this question 
was unclear, since several of the patients had unclean feet and long toenails. Some patients 
were also found to have skin-crackers, fungus and prayer marks.  
 
The issue of external validity is the question to what extent one may generalize and apply the 
conclusion derived from this study to the general population. Since we have only included 
hospital outpatients with a duration of diabetes between 5 and 11 years, we can not conclude 
anything regarding the DPN prevalence in Bangladesh at large. However, the BIRDEM 
hospital controls the diabetic care in Dhaka. Therefore the sample population most likely 
reflects the diabetic outpatient hospital population in Dhaka.  We would have needed a much 




5.3. Conclusion  
Even though this study is relatively small and the findings should be articulated with caution, 
the data regarding DPN from the South Asian population, where the prevalence of type 2 
diabetes is likely to increase substantially in the near future is scare. Therefore, the data is 
vital in order to develop appropriate preventive measures and improve the quality of care for 
diabetic patients.  
 
In summary, it can be concluded that the overall DPN prevalence in this population was 
19.7%, and thus lower compared with the rates presented in European studies. The risk for the 
occurrence of DPN is related to increasing age, longer duration of diabetes and poor glycemic 
control. In addition, we found insulin treatment and low socioeconomic status to be 
independent risk factors for DPN in this population.  
 
Despite of the importance of DPN investigation in order to provide preventive measures and 
quality of care, we lack simple accurate and readily reproducible method to measure the rate 
and extend of DPN in low incoming countries. The inexpensive and feasible tests presented in 
this study, especially the monofilament and balance test, may be applied in health care 
services in developing countries to identify patients at high risk of developing foot 
complications. These risk patients should be identified in time and receive improved care 
through proper education and training in order to diminish the risk of impairments and 
disabilities, and further to reduce the burden and cost for both to the individual and society at 
large. 
 
5.4. Recommendations   
In addition to useful experience and observations made during the field work, the data 
presented in this study generated several questions and issues that warrant further evaluation. 
First of all is the finding of early age for the onset of diabetes and its complication in 
Bangladesh. This has been reported in other studies, but no conclusion has been drawn. In a 
society like Bangladesh, where the resources are already diminutive relative to its population 
size, the increasing life expectancy and early onset of diabetes and its complications may 
dramatically raise the burden and expenses of the health care system. 
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Insulin is thought to be the vital and life saving drug for the diabetic patient. Therefore, the 
association between DPN and insulin treatment even after controlling for age, duration of 
diabetes and glycaemic control deserve further attention.  
 
Good physical fitness and muscle strength has been hypothesized to avert diabetes, and may 
delay the onset of insulin treatment and diabetes complications. In a country where physical 
activity and exercise is not practised, it is important to identify useful means to increase the 
physical fitness level. Therefore appropriate physical activity habits suitable for the local 
cultural context need to be developed and tested, in addition to an assessment of the current 
physical fitness level.  
 
The last issue is related to the knowledge regarding DM, DPN and diabetic foot. In order to 
prevent diabetic complications the community needs to be mobilized.  The patient is in the 
end responsible for his own health, and needs to be aware of the risk factors. The attention 
regarding the diabetic foot problems should be increased to prevent complications and reduce 
the total burden for the diabetic patient, his family, the community and the country 
Bangladesh. 
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Aims/hypothesis The purpose of the study was to estimate the prevalence and risk factors for 
diabetic peripheral neuropathy (DPN) in type 2 diabetic outpatients attending the BIRDEM 
hospital, Bangladesh.  
 
Materials and methods Type 2 diabetic outpatients, diagnosed 5-11 years prior to the 
investigation was randomly drawn. DPN was assessed using the Neuropathy Symptom Score 
(NSS) and Neuropathy Disability Score (NDS). Data about demographics, blood pressure, 
height, weight, waist and hip circumference, and random blood and urine samples were 
collected.  
 
Results Two hundred and ninety four (139 men, 155 women) type 2 diabetic outpatients were 
studied. The overall DPN prevalence was 19.7 %, male (20.9%), female (18.7 %). The 
prevalence increased with age (from 11.1% in the 23-40 year-old group to 32.3% in the 60-80 
year-old group) and duration of diabetes (from 14.1% in patients with 5 years to 29.2% in 
patients with 9-11 years duration). Age > 60 years (OR 4.2, 95% CI 1.4-12.3), low/normal 
WHR (OR 3.8, 95% CI 1.6-9.3), income < 800 TK (OR 3.1, 95% CI 1.1-9.3) and insulin 
treatment (OR 2.0, 95% CI 1.0-4.0) were independent, significant risk factors, longer duration 
of diabetes (OR1.2 95% CI 1.0-1.4), and higher HbA1c OR1.1, 95% CI (1.0-1.3) were 
marginally independent, significant risk factors for DPN. 
 
Conclusions/interpretations We observed a DPN prevalence of 19.7%. Higher age, low 
socioeconomic status, treatment with insulin, longer duration of diabetes and poor glycemic 
control were risk factors for DPN. Necessary measures should be taken to control diabetes 
complication and secure quality of care.  
 






Chronic peripheral sensorimotor symmetrical neuropathy (DPN)  accounts for approximately 
75% of the diabetic neuropathies(1). It is defined as the presence of symptoms and/or signs of 
peripheral nerve dysfunction in people with diabetes mellitus (DM), after exclusion of other 
causes(2). The primary symptom of DPN is loss of sensation in the toes which extends to 
involve the feet and leg in a stocking distribution. Some patients complain about numbness 
and pain, but most frequently the disease progresses insidiously and undetected. If no action is 
taken, foot callus, ulceration and infection might develop and further turn into distressing and 
painful impairments.The foot ulcers among diabetic patients are mostly of neuropathic origin, 
and therefore eminent preventable. Up to 85% of amputations among diabetic patients are 
preceded by foot ulcers(3). The prevalence of DPN varies in the literature from 5-100%(4), 
which may reflect the different diagnostic criteria and diverse study populations. The 
International diabetes federation has estimated that it affects 20-50% of people with DM(5). 
Age, duration of diabetes and poor glycaemic control are recognized as risk factors for DPN, 
while cigarette smoking, retinopathy, hypertension, obesity, hyperlipidaemia and 
microalbuminuria has been pointed out as potential risk indicators(1). 
It has been reported that the risk of diabetes related amputations and the prevalence of 
diabetic foot ulcers is significantly lower in Asians compared to Europeans in the U.K.(6-8). 
The reduced risk in Asians was found to be related to the lower levels of peripheral arterial 
disease (PAD) and DPN, but the reason is not fully understood. Ethnic differences and 
unknown risk factors in different populations have been proposed. There are few DPN studies 
from the South-Asian region, where the prevalence of type 2 diabetes and its complications 
are predicted to rise extensively in the coming years(9). To the best of our knowledge, there 
are no published data regarding the DPN prevalence in Bangladesh where the prevalence of 
type 2 diabetes has been reported to be 8,1% in the urban areas(10). The aim of this study was 
to estimate the prevalence of DPN and to identify its risk factors in type 2 diabetic patients 
attending the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and 
Metabolic Disorders (BIRDEM), with a view to provide necessary data to identify differential 
risk factors which may ensure improved preventive measures and care for diabetic patients. 
Subjects and methods 
A cross-sectional study was carried out from July 2006 to September 2006 in the outpatient 
department (OPD) at the BIRDEM hospital, located in Dhaka, Bangladesh. BIRDEM is a 
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550-bed general tertiary level hospital with the most modern disciplines. The OPD is mainly 
dedicated to diabetic patients, the turnover is approximately 3000 patients, including 60 to 70 
new patients, per day(11). All the subjects for investigation were recruited from BIRDEM. 
The inclusion criterion was type 2 diabetic outpatients diagnosed in accordance with the 
WHO criteria within 5-11 years prior to the investigation. The exclusion criteria were any 
known rheumatic disease, vitamin B12 deficiency, alcoholism, intoxication, hypothyroidism, 
paraneoplastic disorders, cerebral vascular disease, Parkinson disease, uraemia and acute or 
chronic musculoskeletal disorders. 
  
The patient list for the OPD was made three days prior to the doctor appointment. The list was 
then distributed among ten investigation rooms, with two to six doctors in each room. In order 
to match the investigating team members’ (the researcher and two assistants) capacity, one, 
two or three examination room(s), depending on the number of doctors attending, was 
randomly drawn every day. The doctors were well informed of the research objectives, the 
procedures and the inclusion and exclusion criteria. The doctors informed and requested the 
appropriate patients to make contact with the research department after the initial 
examination. The patients were informed about their right to withdraw and restrict their data 
from analysis at any stage. Informed consent was secured prior to inclusion in the study, 
which was carried out according to the Helsinki declaration. The Ethical Committee of 
Medical Research in Norway and the BIRDEM hospital approved the protocol. 
 
A total of 303 patients were examined. One patient withdrew from the study, and seven 
patients were excluded due to complications related to stroke, ankle and low back operations. 
One patient was excluded due to diabetes duration of less than 4 years. Subsequently, a total 
of 294 patients remained for analyses.  
 
The laboratory analyses were done at the BIRDEM hospital. Eight ml whole blood was drawn 
from each patient, and urine was collected in a glass test tube (6ml). Glycosylated hemoglobin 
(HbA1c) was analysed by high-performance liquid chromatography (HPLC). Good glucose 
control was defined as HbA1c < 7.0 (12). The total cholesterol (TC) was measured using 
conventional laboratory techniques. The urine creatinine level was measured by the Alkaline  
Picrate (Hitachi 704 Japan) method in the biochemical laboratory, and urine albumin by the 
Nephelometry (Bn-2 Nephelometer) method in the immunology laboratory(13;14). The 
detection limit for albumin was 11.6 mg/l. The urinary albumin-to-creatinine ratio (UACR) 
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was calculated. A value < 2.5 mg/mmol was defined as normal, 2.5-30 mg/mmol as 
microalbuminuria and >30 mg/mmol as manifest proteinuria(15).  
  
Information regarding diagnosis, registration date, medication, height and the present day’s 
blood pressure (BP) and weight was collected from the patients’ medical record book. High 
BP was defined as systolic blood pressure > l40 mmHg or diastolic pressure > 90 mmHg(16). 
The body mass index (BMI) was calculated according to the formula BMI = weight/height2 
(kg/m²). Waist and hip circumference was measured with a non-stretchable measuring tape. 
Waist girth was measured through the midway between the lower border of the ribs and the 
iliac crest on the mid-axillary line. Hip circumference was measured to the nearest centimetre 
at the greatest protrusion of the buttocks just below the iliac crest. Both measurements were 
done with the patient standing and breathing normal. A WHR > 0.90 in men and > 0.80 in 
women was defined as abdominal obesity(10).  
 
A structured questionnaire with clear and simple questions was made for this study. An 
academic in the field of community medicine translated the questionnaire into Bengali. It was 
used to prevent any language misinterpretation between the researcher and the participants. 
The Bengali version was pilot tested on five patients fulfilling the inclusion criteria. There 
were no remarks or misunderstandings, and no changes were made.  
 
Information regarding demographic and socioeconomic factors (age, gender, average monthly 
income per family member, years of education) and lifestyle characteristics (smoking history, 
protein intake) was obtained by interview. The Neuropathy Symptom Score (NSS)  was 
recorded by interview following the standard guidelines(17). The NSS consist of five 
questions; each assigning points in order to calculate the total symptom score.  The total 
maximum abnormal symptom score was 9 points.  
5. Burning/numbness/tingling (2 p) or Fatigue/ Cramping /Aching feelings (1 p) in the 
lower extremity 
6. Symptoms present in the feet(2 p) or in the calf (1p)  
7. Nocturnal exacerbation of the symptoms (2 p) or present equally at day and night (1 p) 
8. The Symptoms awake the patient from sleep (1 p) 
9. Walking (2 p) or standing (1 p) manoeuvres reduce the symptoms   
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The Neuropathy Disability Score (NDS) consists of four clinical tests on both feet(17). The 
procedure was explained and the tests applied on the patient’s hand prior to the examination. 
The patient had to close the eyes during the examination. Each test was assessed with points 
to calculate the total disability score. The total maximum abnormal disability score was 10 
points.  
8. Achilles tendon reflex: The broad end of the reflex hammer (Babinski) was applied at 
the Achilles tendon. Jerk with reinforcement (1p), no jerk (2p).  
9. Vibration perception: A 128-Hz vibrating fork (Hartmann C128) was applied 
longitudinally on the 1st toe three times with at least one false application (not-
vibrating fork). The patient was required to tell which application that was vibrating or 
not. Two of three right responds were set to be a correct answer (0p), two of three 
wrong responds were an incorrect answer (1p).  
10. Thermal sensation (cold sponge):  One cold and one room temperature sponge was 
applied on the dorsum of the foot. The patients were required to tell which application 
that was cold or normal, correct answer (0p), incorrect answer (1p).  
11. Tactile sensation (pin-prick): The reverse end of the turning fork and tendon hammer, 
sharp and dull respectively, was applied at the cuticle of the 1st toe. The patients were 
required to tell which application that was sharp or dull, correct answer (0p), incorrect 
answer (1p). 
A total symptom score of 3-4 points was considered as mild symptoms, 5-6 points as 
moderate symptoms and 7-9 points as severe symptoms. A total disability score 3-5 points 
was considered mild disability, 6-8 points as moderate disability and 9-10 points as severe 
disability. The minimum acceptable criteria for diagnosis of DPN were moderate disability, 
with or without symptoms, or mild disability with moderate symptoms. Mild disability alone 
or with mild symptoms was not considered adequate to make a diagnosis of DPN(17). 
 
The data was entered in the SPSS 14.0 for Windows software. The variables age, diabetes 
duration and income were categorised. Descriptive statistics were used in order to identify the 
DPN prevalence, determined in simple percentages. For comparison of baseline variables 
between the groups, the Chi-Square (χ²) or Fisher's exact test was preformed for categorical 
data, the t-test for normally distributed continuous data and the Mann-Whitney test for non-
normally distributed continuous data.  Spearman correlation was used to assess the 
relationship between variables of interest. Bivariate and multivariate logistic regression 
analyses were preformed in order to identify factors associated with DPN and adjust for 
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potential confounding factors. Odds ratios (OR) with 95 % confidence interval (CI) were 
provided. Statistical significance was set at p < 0.05. All tests performed were two tailed. 
 
Results 
There were 155 (52.7%) female and 139 (47.3%) male subjects (Table 1). The mean age was 
50.8 + 10.6 years, females being significantly younger (48.7 + 10.7) than men (53.1 + 9.9).  
The mean duration of diabetes was 7.0 + 1.8 years (Table 1), and was similar in males and 
females. The overall prevalence of DPN in this population was 19.7 %, and fairly comparable 
for male (n=29, 20.9%) and female (n=29, 18.7 %) patients. 
 
Table 1 Demographics and clinical variables related to DPN, Dhaka, Bangladesh, 2006 





subjects (n=236)  
p-value for the 
difference 
  Mean + SD t-test 
Age (years) 293 50.8 + 10.6 55.1 + 10.5 
  





7.0 + 1.8 7.7 + 1.9 6.9 + 1.8 0.05 
Waist/hip ratio  289 0.93+ 0.06 0.9333 + 0.0599 0.9324 + 0.0603 NS 
BMI (kg/m²) 294 24.43 + 3.35 24.16 + 3.60 24.50 + 3.29 NS 
HbA1c (%) 293 8.75 + 2.20 9.54 + 2.52 8.56 + 2.08 <0.01 
Total cholesterol 
(mg/dl) 
293 190.45 + 31.83 191.63 + 34.29 190.17 + 31.27 NS 
  Median (Interquartile Range) Mann-Whitney 
test  
Monthly income pr 








Education (years) 294 6.5 (12) 5.0 (12) 8.0 (12) NS 
Systolic BP (mmHg) 294 120 (10) 130 (20) 120 (10) NS 
Diastolic BP (mmHg)  294 80 (0) 80 (0) 80 (0) NS 
Albumin creatinin 
ratio (mg/mmol) 
287 0.00 (0) 0.00 (15.3) 0.00 (0) < 0.05 








40.8 % (120) 
52.0 % (153) 
7.2 % (21) 
60.3 % (35) 
36.2 % (21) 
3.5 % (2) 
36.0 % (85) 





Low protein intake 
Middle protein intake 




20.7 % (61) 
49.7 % (146) 
29.6 % (87) 
34.5 % (20) 
44.8 % (26) 
20.7 % (12) 
17.4 % (41) 
50.8 % (120) 










73.8 % (217) 
15.0 % (44) 
11.2 % (33) 
65.5 % (38) 
19.0 % (11) 
15.5 % (9) 
75.8 % (179) 
14.0 % (33) 




* Fisher's Exact Test  
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An increasing trend in prevalence of DPN with increasing age was observed, from 11.1% in 
those aged 23-40 years to 32.3% in those aged 60-80 years (OR 3.8, 95% CI 1.4-10.4) (Table 
2). The prevalence of DPN increased steadily with increasing duration of diabetes (OR1.2, 
95% CI 1.0-1.4) (Table 2), from 14.1% in those diagnosed 5 years prior to the investigation to 
29.2% in those having 9-11 years duration of diabetes. The prevalence rate also differed 
following the treatment procedures for diabetes. The prevalence of DPN was 13.7% in the 
oral antidiabetic treated group, compared to 29.2 % in the insulin treated group (OR 2.6, 95% 
CI 1.4-4.7) (Table 2). There were no significant correlation between the treatment procedure 
and age, or between the treatment procedure and duration of diabetes. There was detected a 
significant correlation between the treatment procedure and income (rSp = 0.00135841; p< 
0.001). The prevalence increased with decreasing income from 9.4% in the group earning > 
3000 TK per month to 25.3% in the group earning < 800 TK per month (OR 3.3, 95% CI 1.3-
8.8), and with decreasing protein intake from 13.8 % in the group having a high protein intake 
compared to 32.8% the group having a low protein intake (OR 3.1, 95% CI 1.4-6.9) (Table 2). 
There was a significant positive correlation between protein intake and HbA1c (rSp = 
0.00052095; p< 0.01), and between the protein intake and income (rSp = 0.000001; p< 
0.001). 
  





p-value for the 
specific range 










Age < 40 years 
Age 41-59 years 












3.8 (1.40- 10.38) 
Diabetes duration 
(continuous) 
294 0.04 0.04 1.2 (1.01-1.36) 
Income > 3000 TK   
Income 801-2 999 TK 












High protein intake 
Middle protein intake 




















HbA1c (continuous) 293 0.003 < 0.01 1.2 (1.06-1.37) 
Oral treatment 










Insulin treatment 119 < 0.01 2.6 (1.41-4.74) 
Normal BP 







UACR < 2,5 mg/mmol 
UACR 2,5-3,0 mg/mmol 














Table 3 Odds ratio (OR) and 95% CI of DPN by the following risk factors in a multivariate 
model, Dhaka, Bangladesh 2006  
 
 
Age > 60 years (OR 4.2, 95% CI 1.4-12.3), treated with insulin (OR 2.0, 95% CI 1.0-4.0),  
low/normal WHR  (OR 3.7, 95% CI 1.5-9.3), and income < 800 TK (OR 3.2, 95% CI 1.1-
9.4), remained as statistically significant risk factors, whereas duration of diabetes (OR1.2, 
95% CI 1.0-1.4), and HbA1c (OR 1.1, 95% CI 1.0-1.3), remained as borderline, statistically 
significant risk factors for DPN after controlling for potential confounding factors included in 
the multivariate logistic regression model (Table 3).   
 
Discussion 
The overall prevalence of DPN in this study was 19.7 %. It is lower compared to European 
studies using similar diagnostic criteria(12;17;18), which have reported an overall DPN 
prevalence of 32.1% (mean age: 63 years, mean duration of diabetes: 6 years)(17), 35.4% 
(mean age: 61.3 years, mean duration of diabetes: 9.7 years)(18) and  60.0 % (mean age: 57.2 
+ 10.3, mean duration of diabetes: 8.52 + 7.13 years)(12) among type 2 diabetic hospital 
outpatients. The prevalence rate in our study was similar to the prevalence rate found in a 
Factors p-value for the 
entire variable  
p-value for the 
specific range 
Odds Ratio (95% 
CI) 
Age < 40 years  
Age 41-59 years 






















0.006 <0.01 1.0 
3.7 (1.47-9.34) 
Income > 3000 TK 
Income 801-2 999 TK 







Diabetes duration (continuous)  0.07 0.07 1.2 (0.99-1.40) 
HbA1c (continuous) 0.09 0.09 1.1 (0.98-1.31) 
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study from a diabetic centre in India, reporting a neuropathy prevalence of 19.1% among type 
2 diabetic outpatients (mean age in the DPN-group: 62 + 8 years, mean duration of diabetes: 
12 + 8 years)(19). The results from India may indicate that the diabetes complication in 
Bangladeshi subjects have initiated earlier both with respect to the age of the patient and 
duration of diabetes. However, the diagnostic criteria used in the study from India differ from 
ours and therefore no firm conclusions can be made.  
We used similar diagnostic criteria as studies from the U.K. showing a lower DPN prevalence 
among type 2 diabetic South-Asian patients compared with European patients living in the 
U.K. even after adjusting for age(6;7). However, the observed lower DPN prevalence rate in 
our study compared to the European studies may be explained by the duration of diabetes 
selection of the study population. The mean age of our subjects was 50.8 + 10.55 years, which 
may confirm that the diabetes population in this part of the world is relative young compared 
to the West(10;20).  
The results from the multiple logistic regression analysis revealed that age and duration of  
diabetes(1;12;16-19;21;22) are statistically significant risk factors for DPN. Duration of 
diabetes was only a marginally, statistically significant risk factor in our study, and may be 
explained by possible late diagnosis. We found no difference in the DPN rate between the 
genders which also has been confirmed by others(12;16-19;21;22). Our figures showed an 
numerical higher occurrence of DPN among smokers and patients with high BP, 
hypercholesorelemina and potential mikroalbuminuri/proteinuri, but like others(12;16), we 
could not identify them as statistically significant risk factors. This is in contrast with other 
reports(21;23;24), and may have been due to the limited sample size. 
We found a significant correlation between the treatment procedure and income, and between 
the treatment procedure and DPN. This is in agreement with several other studies showing 
that  subjects treated with insulin are at increased risk for DPN(12;19;21). This may also be a 
possible consequence of the welfare system provided by the BIRDEM hospital. Insulin is 
supplied free or at a subsidized cost to those who can not afford to pay, which may have 
resulted in more insulin treatment among the poorer patients. We found low income and 
low/normal WHR to be significant risk factors for DPN, in addition to a significant 
correlation between protein intake and income and between protein intake and HbA1c. This is 
in agreement with findings from India indicating that poor socioeconomic background 
contributes to diabetic foot complications(20). Possible explanations for the phenomenon 
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could be that poor people are less likely to use health services(25), which might result in late 
diagnosis and uncontrolled DM.  
 
Despite of the importance of DPN investigation for the quality of care provided to the diabetic 
patients, we lack a simple accurate and readily reproducible method of measuring DPN.  
Population, recruitment, diagnostic criteria and modes of investigation are factors that may 
influence the differential results reported in various studies. We have used similar diagnostic 
procedures as those used in Young’s  study from the U.K. involving 6487 type 2 diabetic 
patients(17). The method provide simple clinical criteria without referring to electrodiagnostic 
studies, as highly sophisticated and expensive procedure is less suitable to put into practice in 
developing countries like Bangladesh.  
 
Our data suggest that the prevalence of DPN increases with age, poverty and type of treatment 
provided and subtly by the duration of diabetes and poor glycemic control. Our results were 
generated from a relatively small study, the DPN prevalence rate should therefore be 
interpreted with some caution. However, the findings of early age for the onset of diabetes 
and its complication in Bangladesh, and that insulin treatment may lead to increased risk for 
DPN deserve further attention. Moreover, the data of DPN from the South Asian population, 
where the prevalence of type 2 diabetes is likely to increase substantially in the near future, is 
scarce. Therefore the data on DPN from this population is vital in order to improve the 
preventive measures and the quality of care related to foot complication among type 2 
diabetic patients.  
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Abstract: 250 words 




Aims/hypothesis The purpose of this study was to assess the sensory and musculoskeletal 
lower-leg function among type 2 diabetic outpatients, with and without DPN, in Bangladesh, 
in a valid and practical manner suitable for low income countries, in order to identify diabetic 
patients at risk for developing foot complications. 
 
Materials and methods We randomly recruited 58 (19.7%) DPN subjects and 236 non-DPN 
subjects. The plantar protective sensation (Semmer-Weinstein 5.07 g monofilament), 1st MTP 
and ankle joint rang of motion (ROM) (Goniomery), muscle strength (Kendall’s muscle test) 
and balance (one and two leg static balance, tandem walk) was evaluated. 
 
Results The joint range of motion (ROM) for the 1st MTP dorsal (p=0.03) and plantar flexion 
(p=0.003), the Tibiales anterior (p=0.03) and Flexor hallucis (p=0.02) strength, balance 
(<0.001) and protective sensation (p<0.001) was statistically significant reduced in the DPN-
group. The difference remained for the balance (OR1.4, 95% CI 1.1-1.6), protective sensation 
(OR 2.0, 95% CI 1.5-2.6) and Flexor hallusis (OR 3.2, 95% CI 1.1-9.4) after controlling for 
age, sensibility, balance, 1st MTP plantar and dorsal flexion ROM, and Tibiales anterior and 
Flexor hallucis strength in a multivariate logistic regression model. 
  
Conclusions/interpretations The DPN subjects preformed worse on all the tests, especially for 
the protective sensation and balance test. The inexpensive and feasible tests presented, may be 
applied in health care services in developing countries to identify diabetic patients at high risk 
for developing foot-complications. These patients should receive improved care to prevent 
and reduce the burden and cost for both the individual and the society.  
 
Key words Type 2 diabetes, peripheral neuropathy, balance, strength, physical therapy 





Chronic peripheral sensorimotor symmetrical neuropathy (DPN) is the most common form of 
diabetic neuropathy, and accounts for 75% of the diabetic neuropathy syndromes(1). The 
primary symptom is loss of sensation in the toes which extends to involve the feet and leg in a 
stocking distribution. Callus formation, numbness and pain may affect some patients, but 
most frequently the disease progresses insidiously and undetected. Sural nerve biopsy has 
revealed that patients with DPN have a 30% reduction in the Sural nerve fibre density 
compared with patients who have no evidence of DPN(2). As the disease progresses, motor 
manifestations, reduced joint range of motion (ROM) decreased proprioception and increased 
reflex time may become apparent(1;3-6). Partial restriction of daily activities has been 
reported in 74% of type 2 diabetic patients with DPN(7), in addition to decreased physical 
fitness(5), increased risk of falling(8), mobility impairments and activities of daily living 
(ADL) disability(9). Up to 85% of the diabetes related  amputations are preceded by foot 
ulcers(10), and the foot ulcers are more likely to be of neuropathic origin(11).  
 
Considering the motor, sensory and functional impairment caused by DPN, an evaluation of 
the patient’s level of functioning become important in order to avert further disability and 
reduce the enormous medical, economic and social burden for both the individual and the 
societies  Few studies have used clinical performance measures to study the relationship 
between diabetes, DPN and physical function. There are hardly any DPN studies conducted in 
Asia and to the best of our knowledge no published data from Bangladesh. Here the 
prevalence of type 2 diabetes and its complications are predicted to increase extensively in the 
near future(12), and expensive and modern equipment are less likely to be available. The 
attention should be on preventive measures(13), since costly treatment is out of reach for the 
majority of the people. 
   
We have shown that the overall DPN prevalence among type 2 diabetic patients attending the 
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic 
Disorders (BIRDEM) was 19.7%. The prevalence of DPN increased with age, poverty and 
type of treatment for diabetes and subtly with the duration of diabetes and poor glycemic 
control (submitted). The purpose of this study was to assess the sensory and musculoskeletal 
lower-leg function among type 2 diabetic outpatients, with and without DPN, in Bangladesh, 
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in a valid and practical manner suitable for low income countries, in order to identify diabetic 
patients at risk for developing foot complications. 
 
Methods  
A cross-sectional study was carried out from July 2006 to September 2006. All the subjects 
for investigation were randomly recruited from BIRDEM. The inclusion criterion was type 2 
diabetic outpatients diagnosed in accordance with the WHO criteria within 5-11 years prior to 
the investigation. The exclusion criteria were any known rheumatic disease, vitamin B12 
deficiency, alcoholism, intoxication, hypothyroidism, paraneoplastic disorders, cerebral 
vascular disease, Parkinson disease, uraemia and acute or chronic musculoskeletal disorders. 
A detailed description of the selection has been described previously (submitted). The patients 
were informed of the research objectives, the procedure and their right to withdraw at any 
stage. They gave informed consent prior to inclusion in the study, which was carried out in 
accordance with the Helsinki declaration. The Ethical Committee for medical research in 
Norway and the BIRDEM hospital approved the protocol.   
 
A total of 303 patients were examined. One patient withdrew from the study, and seven 
patients were excluded due to complications related to stroke, ankle and low back operations. 
One patient was excluded due to diabetes duration of less than 4 years. Subsequently, a total 
of 294, 155 female and 139 male patients remained for analysis.  
 
DPN was diagnosed by means of the Neuropathy Symptom Score (NSS) and the Neuropathy 
Disability Score (NDS)(14). NSS was used to identify the severity of neuropathic symptoms, 
the patients were asked about their experience of pain and discomfort in the lower extremities.  
NDS was used to determine the level of disability, derived by examination of the Achilles 
tendon reflex, Vibration perception (128 Hz tuning fork), Thermal sensation (cold sponge) 
and Tactile sensation (pin-prick). The minimum acceptable criteria for diagnosis of DPN were 
moderate disability of neuropathy, with or without symptoms, or mild disability with 
moderate symptoms. The NSS and NDS, in addition to the various demographic, medical and 
social variables recorded for all patients have been described in depth elsewhere (submitted).  
  
The clinical sensory and musculoskeletal lower-leg examination was carried out by the 
researcher. Both feet were assessed for each test. The cutaneous pressure perception 
(protective sensation) was assed using a 10g monofilament (5.07 Semmer-Weinstein)(15) at 
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three validated  plantar sites (the heel, 1st and 5th metatarsal heads)(16). It was applied 
perpendicular to the skin surface with sufficient force to cause the filament to bend before it 
was removed. The application was repeated three times at the same site with at least one 
“false” application, in which no filament was applied(17). In prone position with eyes closed 
the patient was asked if he felt the pressure, and was required to respond “yes/no”.  2 of 3 
correct answers gave 0 points, and 2 out of 3 incorrect answers gave 1 point. The points for 
each test site for both feet were added and categorised into normal (0 points), reduced (1 
point) and absent (2 points) protective sensation. In addition, sum score were calculated. 
 
Balance was assessed by means of a modified index for muscle function test for the lower 
extremity(18). Each test was performed without socks and shoes. The one-leg standing test 
was assessed on both legs, one at the time with eyes open, and the narrow two-leg standing 
test with the feet together and eyes closed. The tests was timed and graded on a three point 
scale. > 30 seconds scored 0 points, 15 – 29 sec: 1 point and 0 – 14 sec: 2 points. For the 
tandem walk the patients walked heel-to-toe on a 2 metre red line with the eyes open. To 
carry out the test without problems scored 0 points, with some problems 1 point and not able 
to carry out the test scored 2 points. In addition, sum score were calculated. 
 
Passive joint range of motion (ROM) was measure with a goniometry(19). Dorsal and plantar 
flexion of the ankle and plantar flexion of the 1st MTP joint was assessed with the patient in 
prone position and 90 degrees knee flexion. For the ankle ROM measurement the stationary 
arm of the goniometry was placed parallel to the lateral midline of the fibula (projecting 
towards the fibular head), and the moving arm parallel to the lateral midline of the calcareous. 
The axis was 1cm distal to the lateral malleoli of fibula. For the 1st MTP the stationary arm of 
the goniometry was placed over the dorsal aspect of the shaft of the first metatarsal bone, and 
the moving arm along the dorsal surface of the shaft of the proximal phalanx. The axis was 
over the dorsal aspect of the MTP joint. Dorsal flexion (extension) of the 1st MTP was 
assessed with the patient standing facing the wall. The 1st toe was placed at the wall, and the 
1st MTP joint and foot in the floor. The stationary arm of the goniometry was placed over the 
planter midline shaft of the first metatarsal bone. The axis was over the plantar aspect of the 
MTP joint, and the moving arm placed along the plantar shaft of the proximal phalanx.  The 
ROM measurements for each joint on both feet were added. 
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The leg muscles were assessed with the patient in standing position without socks and shoes, 
supported by the researcher. For the ankle plantar flexors (Gastrocnemius, Soleus and 
Plantaris) the patient was asked to go up on tiptoe 10 times, and for the ankle extensors 
(Tibialis anterior) the patient was asked to walk 10 steps on the heels. The Flexor and the 
Extensor hallucis muscles were assessed with that patient in sitting position. Resistance was 
applied beneath the proximal and distal phalanx and dorsum of the proximal and distal 
phalanx of the great toe. The patient was asked to keep the toe in the normal position, and not 
let the examiner move the toe in the cranial nor the caudal direction. If the patient was not 
able to do the movement with resistance, he/she was asked to lie down and do the movement 
without resistance according to Kendall’s muscle test(20). The patient was graded on a five 
point scale, five being top score per test. Less than 10 steps/minimal resistance: 4 points, 
holds the test position against gravity: 3 points, moves through a small motion with gravity 
minimized: 2 points and palpable contraction with no joint motion: 1 point. The points for 
each muscle group for both feet were added and categorised into strong (10-8 points) and 
weak (7-0 points). 
 
The data was entered in the SPSS 14.0 for Windows software. Descriptive statistics was used. 
For comparison between the groups, Chi-Square (χ²) test was preformed for categorical data 
and Mann-Whitney test for non-normally distributed continuous data. Spearman correlation 
was used to assess the relationship between lower-leg function variables and the risk factors 
for DPN. A multivariate logistic regression model was build with the DNP-group versus the 
non-DNP-group as the dependent variable, and analyses were preformed in order to adjust for 
potential confounding factors. Odds ratios (OR) with 95 % confidence interval (CI) were 
provided. Statistical significance set at p < 0.05. All tests performed were two tailed.  
 
Results 
Table 1: Protective sensation and Balance measures for the DPN-group and the non-DPN- 
group, Dhaka, Bangladesh, 2006  
 Non-DPN-group 
% (n) 










38.3 % (90) 
32.8 % (77) 
28.9 % (68) 
 
19.0 % (11) 
29.3 % (17) 
51.7 % (30) 
<0.01 





93.6 % (220) 
6.0 % (14) 
0.4 % (1) 
70.7 % (41) 
19.0 % (11) 
10.3 % (6) 





85.1 % (200) 
11.5 % (27) 
3.4 % (8) 
 
55.2 % (32) 
24.1 % (14) 
20.7 % (12) 
< 0.001 
Balance test (n=294)    
Left one-leg standing 
Good 
Problems 










Right one-leg standing 
Good 
Problems 










Narrow two-leg standing 
Good 
Problems 










Tandem Walk  
Good 
Problems 











The protective sensation for all test sites were statistically significant diminished in the DPN-
group compared to the non-DPN-group, especially for the fifth toe (p< 0.001) (Table 1). The 
non-DPN-group preformed better on all parts of the balance test. The right one-leg standing 
test was most statistically significant diminished compared to the left one-leg standing test 
(Table 1). 
 
Table 2: Joint ROM, protective sensation, balance and strength characteristics for the DPN-
group and the non-DPN-group, Dhaka, Bangladesh, 2006  
 Non-DPN-group DPN-group p-value 
 Median IR Median IR Mann-Whitney test 
Sensibility test (sum score) 1.0 2.0 2.0 2.25 < 0.001 
Balance test (sum score) 1 3 2.5 4 < 0.001 
ROM (n=288)      
Ankle Dorsal flexion 20 10 15.5 5 NS (0.13)  
Ankle Plantar flexion 40 5 40 5 NS (0.25) 
1st MTP Dorsal flexion  55 10 50 15 <0.05 
1st MTP Plantar flexion 50 10 45 15 <0.01 
 % (n) % (n) Chi-Square test 
Strength (n=294)    





4.7 % (11) 
93.1% (54) 
6.9% (4) 































The joint ROM for both the ankle and 1st MTP joint was reduced in the DPN-group compared 
to the non-DPN group, but only the dorsal flexion (p=0.03) and plantar flexion (p=0.003) of 
the 1st MTP joint was statistically significant reduced (Table 2). A higher percentage of the 
DPN-group was weak in all the muscle groups compared to the non-DPN group, but the 
difference was only statistically significant for the Tibialis anterior (p=0.03) and Flexor 
hallucis (p=0.02) (Table 2). The sum score for the protective sensation and for the balance test 
was statistically significant diminished in the DPN-group (p<0.001) compared to the non-
DPN-group (Table 2). 
   
Table 3 Odds ratio (OR) and 95% CI of DPN-group versus the non-DPN-group in a 
multivariate logistic regression model , Dhaka, Bangladesh, 2006 
 
The results from the multivariate logistic regression analysis revealed that the DPN-group 
have a higher risk for having poor balance (OR 1.4, 95% CI 1.1-1.6), reduced protective 
sensation (OR 2.0, 95% CI 1.5-2.6) and Flexor hallusis weakness (OR 3.2, 95% CI 1.1-9.4) 
even after controlling for potential confounding factors included in the model (Table 3).   
Variable p-values for the 
differences  
p-value for the 
specific range 
OR (95% CI) 
< 40 years  
41-59 years 







Balance test  0.002 1.4 (1.12-1.64) 
Sensibility test  < 0.001 2.0 (1.50-2.55) 
MTP Plantar flexion NS NS 1.0 (0.94-1.01) 
MTP Dorsal flexion NS NS 1.0 (0.98-1.10) 
Strong Tibiales anterior 





Strong Flexor hallucis 








The monofilament test has been used frequently to detect loss of protective sensation and to 
assess the foot ulcer risk status. We assessed the cutaneous pressure perception by means of 
the Semmer-Weinstein 5.07 g monofilament. We found that the DPN group had significant 
diminished cutaneous pressure perception for the entire protective sensation test even after 
adjusting for age. We found the fifth MTP test site to be the most important test site. This is in 
agreement with Miranda-Palma et al. who reported that the 5th MTP test site had the highest 
sensitivity compared to the hallux, 1st MTP and 3rd MTP test sites(21). 
  
Loss of plantar cutaneous pressure perception contributes to lack of afferent information from 
the somatosensory system(22), which in addition to information from the visual and 
vestibular system, controls the balance. We were not able to assess the DPN and retinopathy 
patients separately. However, large studies have reported that postural control is affected in 
DPN patient even with proper vision(22-24). We used easily arranged and inexpensive 
clinical tests to measure the balance, and found that the DPN group performed significantly 
worse compared to the non-DPN group, on all four parts of the balance test. The results 
remained statistically significant after controlling for age, protective sensation and other 
potential confounding factors (Table 3). Our findings is in agreement with others showing that 
DPN patients perform worse on a one-leg static balance test, compared to controls(4;5;25). 
We found that the difference between the groups for the one-leg standing test was most 
statistically significant for the right compared to the left one-leg standing test. We did not ask 
the patients to identify their dominant and non-dominant leg. It is highly unlikely that this 
may have influenced the results, but may have induced an analytic bias. However, the finding 
is interesting seen together with Cimbiz et al., who reported the right leg to be the dominant in 
the majority of his subjects, and further that the maximal balance reduction in the DPN group 
was found on the dominant leg(5).  
 
We did not assess the plantar foot pressure, but studies using plantar pressure analysers have 
reported that DPN patients have elevated foot pressure in addition to reduced ankle and 1st 
MTP joint ROM(3;26). The determination of the 1st MTP joint ROM has been identified as a 
fairly exact test to identify a foot with elevated plantar pressure, and hence being a foot at risk 
for developing foot ulcers(3). Like Zimney et al. we found a statistically significant difference 
in the 1st MTP joint ROM between the groups, but this difference was lost when we 
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controlled for age, strength, balance and sensibility. Like others we can not report any 
statistical significant difference between the groups for the ankle plantar and dorsal flexion 
ROM measured with a goniometry(27). 
 
The ability to stand on heels and toes are effortless tests that do not require any technical 
equipment, which makes them suitable for population based surveys(28). We found that the 
inability to stand on heels, as a measure of the Tibialis anterior strength, was statistically 
significant worse in the DPN-group compared to the non-DPN-group. This is in agreement 
with previous reports suggesting that more severe impairment is found in the ankle extensors 
(Tibiales anterior) compared to the flexors (Gastrocnemius)(29). However, the findings in the 
literature are conflicting. Andersen et al. found similar degrees of weakness and atrophy of 
the ankle extensors and flexors, and has suggested that the functional differences between the 
ankle extensors and flexors is not caused by selective weakness or atrophy of the ankle 
extensors, but is a consequence of the biomechanical properties of the ankle joint in 
combination with a higher capacity of the ankle flexors(30).  
 
Atrophy of the foot muscles has been said to be closely related to the severity of 
neuropathy(29), and occur prior to the clinically detectable initiation of DPN(31). We found 
that the DPN-group was statistically significant weaker in the Flexor Hallucis muscle 
(innervated by the Tibial nerve), but not in the Extensor Hallucis muscle (innervated by the 
deep Peroneal nerve) compared to the non-DPN-group. This finding remained after 
controlling for confounding factors, and is in agreement with van Schie et al., who reported 
that the Tibial innervated muscles were weaker compared to the Peroneal innervated muscles 
in DPN subjects(32). 
 
In summary, the DPN subjects preformed poorer on all the tests, especially for the protective 
sensation and the balance test. The DPN patients may therefore be at an increased risk of 
falling and more likely to develop secondary disabilities such as fractures, ulcers and 
amputations. The inexpensive and feasible tests presented here may be applied in health care 
services in developing countries to identify diabetic patients at high risk for developing foot-
complications. These patients should be identified in time and receive education and 
improved care in order to diminish the risk of impairments and disabilities, and thereby 
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9.1. Appendix 1 – Questionnaire and Evaluation form  
 
ID number:   ......................... 
Registration no:  ………………. 
Name of the patient:  .......................... 
Phone number:  ..........................  
Date of interview:  .......................... 
Interview taken by:  .......................... 
 
Medical record book: 
Weigh ...............kg   Date: .............. 
Fasting glucose    
 Previous level: ................... Date: ……….  
 Current level: ………….... Date: ………… 
Blood Lipid profile   Date: ................ 
S.Cholesterol: ...................... 
S.TG:   ...................... 
S.HDL:  ...................... 
S.LDL:  ...................... 
Urine test    Date: ................. 
Albumin level: ...................... 
Acetone level: ...................... 
Urine sugar: ...................... 
  
Demographic characteristics: 





Education    ..........................years 
What is your occupation? 
1. Student 
2. House wife 
3. Manual work 
4. Office work 
5. Business 
6. Unemployed  
7. Retired  
 
What is the household’s monthly income?  .........................Tk. 
What is your monthly income?   ..........................Tk. 
 
How is your living situation? 
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o Alone  
o With family 
o Number of family members  …………………… 
 
 
How is your housing condition? 
o Pipe water 
o Electricity  
 
Patient history:  
For how long have you had diabetes?  ........................years  
 
What kind of diabetes treatment do you use? 
o Diet 
o Insulin 
o Tablets  
o Non 
 






o Other  
o Non 
 
Do you have impaired renal function? 
o Yes 
o No 
o Don’t know 
 
Do you have impaired vision? 
o Yes 
o Wear glasses 
o No glasses 
o No 
o Don’t know 
 
Have you had any previous foot ulcer? 
o Yes 
o Left 
o Right  
o Don’t remember 
o No  
o Don’t know 
 
Have you got any lower limb amputation? 
o Yes 
o Left  
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o Right 




Life style and food consumption: 
What is you smoking history? 
o Never smoked 
o Ex-smoker 
o Current smoker 
o Occasionally 
o Daily <10 
o Daily 10-20 
o Daily >20 
 
How much vegetable do you eat? 
o <3 per day 
o 3-7 per day 
o >7 per day 
 
How much wheat /rice/ maize (bread, cereal, chapatti) do you eat? 
o <3 unit per day 
o 3-7 unit per day 
o >7 unit per day 
How much fish do you eat? 
o None or once a week 
o <3 times per week 
o  >3 times per week 
 
How much chicken do you eat? 
o None or once a week 
o <3 times per week 
o  >3 times per week 
 
How much beef do you eat? 
o None or once a week 
o <3 times per week 
o  >3 times per week 
 
How physical active (walk/ run/ bike/ play cricket/work out) are you? 
o <30 minutes per day 
o 30-60 minutes per day 
o 1-2 hours per day 
o 2-4 hours per day 
o > 4 hours per day 
o Never  
 




o cannot do 
 
Have you difficulty in standing for long periods (thirty minutes)?  
o no 
o moderate 
o cannot do 
 
Foot care awareness 
How often you wash you feet? 
o Every week 
o Every day 
o Several times a day 
 




How often you inspect you feet? 
o Every day 
o Every week 
o Every month 
 
What kind of shoe do you wear most? 
o Trainers, “Slip-ons”, casual shoes 
o Slippers, open toe shoes 
o No shoes (barefoot)  
 
 
Neuropathy symptom score 
Do you experience any pain/discomfort in you lower extremity? What kind? (Tick one) 
2 Yes, a burning/numbness/tingling feeling  
1 Yes, a fatigue/ cramping /aching feeling  
0 No   
 
Where are the feelings present? (Tick one)  
2 In your feet?  
1 In your calves?  
0 Elsewhere?  
 
Do you experience any exacerbation of the feelings at night? 
2 Yes, symptoms exacerbate at night  
1 No, Symptoms present day and night  
0 No, Symptoms present at daytime only  
 
Do the feelings wake you up from sleep? 
1 Yes  
0 No  
 
Does any manoeuvre reduce the feelings? (Tick one) 
2 Yes, walking   
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1 Yes, standing   
0 Yes, sitting/lying   
0 Non  
 
Total score          __________ 
___________Symptoms 
 
Maximum abnormal score is 9 
Mild symptoms 3-4, moderate symptoms 5-6, severe symptoms 7-9 
 
Biochemical Examination: 
HbA1c        ........................ 
Random Glucose level    ........................ 
Lipid profile      ........................ 
S.Cholesterol      ........................ 
S.TG       ........................ 
S.HDL       ........................ 
S.LDL       ........................ 
 
Albumin creatinine ratio    ........................ 
Acetone level      ........................ 
Urine sugar      ........................ 
 
Clinical examination: 
BP        ……………… 
 
Anthropometrics parameters:  
Weight      ........................ 
Height                                       ……………… 
BMI       ……………… 
West heap ratio       ……………… 
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Deformity assessment 
Each deformity score 1 when present and 0 when absent, on either foot.  
Deformity Left Right
Hammer or claw toes (PIP in flexion, DIP and MTP in extension)   
Hallux valgus (Prominence 1st metatarsal head, first toe is inclined latteraly)   
Charcot arthropathy (Increased ROM, new bone formation, increased fluid)   
Pes cavus (high arch, the heel is in varus position. Often there is claw toes.)     
Pes plantus ( collapsed arch, medial boarder almost touches the ground)    
Total score (max score is 10 points)      __________ 
 
Muscle strength evaluation 
Gastrocnemius (plantar flexion with the knee extended) 
Grade Performance Left Right 
0 Supine, No contraction is palpable   
1 Supine, Contraction is palpable, no joint motion   
2 Side lying (gravity minimized), moves through a small plantar 
flexion motion  
  
3 Prone (against gravity), moves into plantar flexion and holds the test 
position  
  
4 Stand on one leg with the knee extended, plantar flexion ending on 
tiptoe (light resistance)  
  
5 Stand on one leg with the knee extended, plantar flexion ending on 
tiptoe, 5 repetitions (maximal resistance) 
  
Total score (max score is 10 points)      ________________ 
 
Tibialis anterior (dorsal flexion and inversion of the foot)  
Grade Performance Left Right 
0 Prone, No contraction is palpable   
1 Prone, Contraction is palpable, no joint motion   
2 Side lying, moves through a small dorsal flexion and inversion 
motion with gravity minimized 
  
3 Sitting, moves into dorsal flexion and inversion, and holds the test 
position against gravity 
  
4 Stands on heels, holds dorsal flexion and inversion position (light 
resistance) 
  
5 Stands on heels, holds dorsal flexion and inversion position while 
taking 5 steps (maximal resistance) 
  
Total score (max score is 10 points)      ________________ 
 
Flexor hallucis brevis and longus (Plantar flexion of the 1st MTP and IP joints, additional to 
plantar flexion and inversion of the foot.) 
Grade Performance Left Right 
0 Sitting, no contraction is palpable   
1 Sitting, contraction is palpable, no joint motion   
2 Sitting, moves through a small plantar flexion motion of the 1st toe 
with gravity minimized 
  
3 Supine, moves into plantar flexion of the 1st toe and holds the test 
position against gravity 
  
4 Supine, moves into plantar flexion of the 1st toe and holds the test   
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position against light resistance. Resistance is applied beneath the 
proximal and distal phalanx of the great toe. 
5 Supine, holds the 1st toe in resting position against maximal 
resistance, tested statically. Resistance is applied beneath the 
proximal and distal phalanx of the great toe.  
  
Total score (max score is 10 points)      ________________ 
 
Extensor hallucis brevis and longus (Extension (dorsal flexion) of the 1st MTP and IP joints, 
additional to dorsal flexion of the foot) 
Grade Performance Left Right 
0 No contraction is palpable   
1 Contraction is palpable, no joint motion   
2 Supine, moves through a small extension motion of the 1st toe with 
gravity minimized 
  
3 Sitting, moves into extension of the 1st toe and holds a test position 
against gravity 
  
4 Sitting/supine, moves into extension of the 1st toe and holds test 
position against light resistance. Resistance is applied to the dorsum 
of the proximal and distal phalanx of the great toe 
  
5 Sitting/supine holds the 1st toe in resting position against maximal 
resistance, tested statically. Resistance is applied to the dorsum of 
the proximal and distal phalanx of the great toe 
  
Total score (max score is 10 points)      ________________ 
 
Reflex evaluation 
Patellar tendon reflex  
  Left Right 
Absent  2   
Present with reinforcement 1   
Normal: jerk into the knee extension 0   
Total score (max score is 4 points)     ___________ 
 
Neuropathy disability score 
Ankle reflex (tendon hammer) 
Grade Performance Left score Right score 
2 Absent    
1 Present with reinforcement   
0 Normal   
 
Vibration (128 HZ turning fork at hallux) 
 Right foot: Wrong (W) or Correct (C) Left foot: Wrong (W) or Correct (C) 
1st   
2nd   
3rd   
 
Grade  Performance Left score Right score 
1 Reduced/absent: 1 of 3 correct answers   
0 Present: 2 of 3 correct answers   
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Pin prick (pencil and cotton wool, dorsum of foot) 
Grade  Performance Left score Right score 
1 Reduced/absent: incorrect answers   
0 Present: correct answers   
     
Temperature (warm/cold sponge, plantar side) 
Grade  Performance Left score Right score 
1 Reduced/absent: incorrect answers   
0 Present: correct answers   
Total score        ______________________ 
_________Sign 
 
Points per side, thus the maximum abnormal score is 10 
Mild sign 3-4, moderate sign 5-6, severe sign 7-9 
 
Monofilament test (Cutanus pressure perception/Sensitivity) 
Repeat the application twice at the same site with at least one “false” application, in which no 
filament is applied. Protective sensation is present if the patient has 2 of 3 correct answers per 
site. Protective sensation scores 0, absent protective sensation scores 1. 
 
Left foot – plantar site, Wrong (W) or Correct (C) 
Application Heel : 1st metatarsal head 5th metatarsal head 
1st    
2nd    
3rd    
Total correct answers    
Protective sensation YES=0 NO=1 YES=0 NO=1 YES=0 NO=1 
 
Right foot – plantar site, Wrong (W) or Correct (C) 
Application Heel : 1st metatarsal head 5th metatarsal head 
1st    
2nd    
3rd    
Total correct answers    
Protective sensation YES=0 NO=1 YES=0 NO=1 YES=0 NO=1 
 
Refill time  
Capillary nail refill time of great toe 
Point Refill time Left Right 
2 >5 seconds   
1 2-5 seconds   
0 < 2 seconds   
Total score (max score is 4 points)     ______________________ 
 
Pedal Pulse  
Each pulse score 0 when present and 1 when absent, on either foot. 
 Left  Right 
Posterior tibial   
Dorsalis pedis   
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Total score (max score is 4 points)     ______________________ 
 
Ulcer assessment 
Modified Meggit-Wagner Ulcer Classification 
Points ulcer Left Right 
0 No   
1 superficial ulcer   
2 full-thickness ulcer   
Total score (max score is 4)       ________________ 
 
Range of motion evaluation 
Ankle joint: Dorsal flexion (dorsal surface moves in cranial direction)  
Points  Range of motion Left Right
2 Absent: +10-0 degrees   
1 Reduced: 0-10 degrees   
0 Normal: 10-20 degrees   
Total Score (max score is 4 points)     _____________________ 
 
Ankle joint: Plantar flexion plantar surface moves in caudal direction (0-45) 
Points  Left Right 
2 Absent: +10-0 degrees   
1 Reduced: 0-20 degrees   
0 Normal: 20-45 degrees   
Total Score (max score is 4 points)     ______________________ 
 
1st toe MTP Extension (dorsal flexion) 
Points  Range of motion Left Right
2 Absent +10-0   
1 Reduced 0-20   
0 Normal 20-45   
Total Score (max score is 4 points)     _____________________ 
 
1st toe: MTP Flexion (plantar flexion)  
Points  Range of motion Left Right
2 Absent: +10-0 degrees   
1 Reduced: 0-20 degrees   
0 Normal: 20-45 degrees   
Total Score (max score is 4 points)     _____________________ 
 
 
Modified Index of Muscle Function - IMF Balance and coordination 
IMF is a function test for the lower extremity. There are 13 parts, if the patient can not 
perform the two first once, the test will be stopped. The test is preformed without shoes, if not 
it must be stated. 
 




Balance and coordination 
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One leg standing with eyes 
open for 30 seconds 
 
0 = > 30 sec 
1 = 15 – 29 sec 
2 = 0 – 14 sec 
  
Narrow two leg standing 
with the eyes closed for 30 
seconds 
0 = 0 = > 30 sec 
1 = 15 – 29 sec 
2 = 0 – 14 sec 
 
Walk forward on a 2 meter 
line with eyes open 
0 = no problems 
1 = with problems 








9.2. Appendix 2 – Informed Consent Statement 
 
The researcher is Kjersti Mørkrid from the University of Oslo. The title of the study is: 
“The prevalence of and risk factors for diabetic peripheral neuropathy, additional to the level 
of functioning among Bangladeshi diabetic out patient diagnosed five to ten years ago” 
  
You may refuse to say yes and not participate in this study. You should be aware that even if 
you agree to participate, you are free to withdraw at any time. If you do withdraw from this 
study, it will not affect your relationship with this unit or the services it may provide to you in 
the future.  
 
The purpose of this study is to describe the extent of and risk factors for developing foot 
problems related to diabetes, and to describing the level of functioning relating to everyday 
life activities such as walking and bending. 
 
You will be asked to make you medical record available for the researcher. An interpreter will 
ask you questions regarding your demographics, medical history and lifestyle. Your feet will 
examined by the researcher, and you will be asked to do activities related to every day life. 
The examination will take approximately one hour. A few patients might feel some 
discomfort during the examination, but there is no anticipated risk in participating in the 
research. The benefit is that you will get a thorough examination of you feet. The research 
findings might be used in order to prevent diabetic foot complications. You will not be paid, 
but refreshments are available during the examination.   
 
The researcher will use a study number, so your name will not be associated in any way with 
the information collected about you or with the research findings from this study. The 
researcher will not share information about you unless required by law or you give written 
permission. By saying yes to participate in the research you give permission for the use and 
disclosure of your information for purposes of this study. You may withdraw your consent to 
participate in this study at any time. You have the right to cancel your permission at any time, 
by sending your written request to:  Kjersti Mørkrid, Gjøvikgt 1b, 0470 OSLO, NORWAY.  
 
I have had the opportunity to ask, and I have received answers to, any questions I had 
regarding the research.  If I have any additional questions about my rights as a research 
participant, I may cal (?) or write an e-mail (kjersti.morkrid@studmed.uio.no) to the 
researcher.  By saying yes I affirm to participate in the research.   
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Picture six: The Achilles tendon reflex (Babinski hammer) 
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Picture eight: Ferdous Ara (Urme) marking the Eppendorf tubes 
